Your browser is no longer supported. Please, upgrade your browser.
We’ve redesigned our maps and bubbles! Read more about the new features here. ×
Settings
IWM [NYSE]
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.16%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month5.05%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter4.22%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y5.89%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year5.24%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range103.15 - 123.30 Perf YTD2.47%
Dividend1.60 P/FCF- EPS past 5Y- ROI- 52W High-0.58% Beta-
Dividend %1.31% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low18.83% ATR1.43
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)59.14 Volatility0.77% 1.14%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.65 Prev Close123.25
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume34.69M Price122.58
Recom- SMA201.83% SMA503.23% SMA2006.89% Volume22,580,370 Change-0.54%
Feb-27-15 07:07PM  10 stocks to buy in March after strong February at CNBC
05:00PM  ChartAdvisor for February 27 2015 at Investopedia
05:00PM  10 stocks to buy for March CNBC
03:59PM  Elliott Management discloses 4Q14 positions Market Realist
01:36PM  Heavy Selling For Such A Small Loss Yahoo Finance Contributors
12:07PM  Emerging Market Dividend Payers Offer High Dividend Yields Market Realist
08:09AM  Nasdaq set to close at monthly all-time high after 15 long years Yahoo Finance Contributors
Feb-26-15 11:27PM  Here Are The Most Important Stock Charts To Watch Now at Forbes
11:00AM  Small-Cap ETFs: Look Beyond the Russell 2000 ETF Trends
Feb-25-15 04:14PM  Pre-Election Year Best in President Cycle, Stocks Typically Soar at TheStreet
04:00PM  STOCKS GO NOWHERE: Here's what you need to know Business Insider
11:29AM  When the Fed finally raises rates, stocks will go nowhere Business Insider
10:14AM  Nice rally, but major indices seem stretched at CNBC
09:14AM  Trade Ideas Yahoo Finance Contributors
09:05AM  Soros raises its position in Spansion amid merger with Cypress Market Realist
07:27AM  Three Points to Consider Yahoo Finance Contributors
Feb-24-15 05:22PM  Pre-election year March, nearly perfect record since 1951 Yahoo Finance Contributors
04:49PM  Don't kid yourself: stocks are just as overvalued today as they were in 2000 Yahoo Finance Contributors
04:08PM  Don't Bet On An Imminent Recession Yahoo Finance Contributors
11:46AM  Long Internet Stocks and Natural Gas For A Trade Yahoo Finance Contributors
11:45AM  Volatility Index signals that the bull has room to run at MarketWatch
10:21AM  The Fed thinks some stocks still look awfully expensive Business Insider
10:14AM  And Stocks take the lead... Yahoo Finance Contributors
09:00AM  Small-Cap ETFs: Slight Differences are Important ETF Trends
Feb-23-15 06:43PM  SunEdison Becomes Jim Chanos' Top Holding in Fourth Quarter Gurufocus
05:43PM  ETF Market Vital Signs, Feb. 23: All Eyes Turn to Yellen at Barrons.com
04:35PM  Don't Fear The Financial Blogger Bulls Yahoo Finance Contributors
04:07PM  A Legendary Market Skill Experience Traders Have at Investopedia
10:21AM  New Highs on the S&P 500 - What is Next? Yahoo Finance Contributors
10:00AM  Mid-Cap ETFs Take the Lead ETF Trends
09:01AM  Signs That US Equities Are Overheated Short-Term Yahoo Finance Contributors
08:01AM  The Ron Popeil Trade Yahoo Finance Contributors
07:47AM  Morning Thoughts: And the Oscar Goes To.... Try the Polenta w/Kale and White Beans Yahoo Finance Contributors
06:01AM  Greek Drama and the Inflection Point Yahoo Finance Contributors
Feb-22-15 04:36PM  Why CEOs make over 300 times more than workers Yahoo Finance Contributors
Feb-21-15 04:17PM  Stocks From Leading Industries Yahoo Finance Contributors
08:37AM  Big Changes On Charts: What Does It Mean For Stocks? Yahoo Finance Contributors
08:00AM  J.P. Morgan Economist: Fed Rate Hike Likely Comes in September at TheStreet
07:40AM  What to expect from the stock market this week Yahoo Finance Contributors
Feb-20-15 09:51PM  The Week Ahead: Run with the Bulls in March? at Forbes
04:45PM  Stock Market Video Analysis 2/20/15 Yahoo Finance Contributors
02:01PM  Finding the Fault in My Market View Yahoo Finance Contributors
02:00PM  ChartAdvisor for February 20 2015 at Investopedia
01:54PM  A Greece deal is in sight and stocks are at record highs Business Insider
Feb-19-15 06:00PM  The absolutely bullish sign for stocks Talking Numbers
04:50PM  Buy Large Cap Stocks, Avoid Pricey Small Caps and Bonds at TheStreet
03:41PM  Why Small-Cap ETFs Could Lead Market Returns ETF Trends
09:30AM  Global Debt: A Scary Situation with Limited Solutions Yahoo Finance Contributors
08:30AM  Initial jobless claims tumble Business Insider
Feb-18-15 10:31PM  Funds increase global equity allocation to 4th highest since 2009 Yahoo Finance Contributors
04:57PM  Q4 Earnings Scorecard: S&P 500 vs. Russell 2000 - Video Blog Zacks
04:01PM  Have Treasurys bottomed? CNBC
03:08PM  Nasdaq's Quest for 5,000: It's Different This Time Around (Right?) at TheStreet
02:31PM  5 Ways to get your retirement savings back on track Yahoo Finance Contributors
09:50AM  Why active management fell off a cliff perhaps permanently Yahoo Finance Contributors
09:16AM  How Our Memories Shape Market Cycles Yahoo Finance Contributors
08:31AM  Prices plunge in January Business Insider
07:47AM  Bond Volatility Risks Market Gains Yahoo Finance Contributors
Feb-17-15 02:34PM  The Bear Market Starts Today Yahoo Finance Contributors
11:50AM  Charting a sluggish, but bullish, S&P 500 breakout attempt at MarketWatch
10:01AM  Treasuries and oil drive stocks higher into a key pivot point Yahoo Finance Contributors
09:59AM  What the Next Bear Market Might Look Like Yahoo Finance Contributors
08:30AM  New York business outlook falls to two-year low Business Insider
08:08AM  Mid-cap stocks handily outperform over the long-term Yahoo Finance Contributors
06:01AM  Economic Clouds Lifting; Political Clouds Remain Yahoo Finance Contributors
Feb-16-15 09:56PM  Global Stock Values: Where to Park Your Cash for the Next Five Years Yahoo Finance Contributors
Feb-15-15 02:28PM  I'm not trying to scare you. I'm trying to help you. Yahoo Finance Contributors
12:06PM  One Reason You Don't Invest... Yahoo Finance Contributors
Feb-14-15 12:52PM  Act As If / Current Market View Yahoo Finance Contributors
07:40AM  What to expect from the stock market this week Yahoo Finance Contributors
Feb-13-15 09:17PM  The Week Ahead: Will Stocks Melt Up? at Forbes
05:06PM  Stock Market Video Analysis for Week Ending 2/13/15 Yahoo Finance Contributors
05:01PM  Europe vs. US CNBC
02:27PM  ChartAdvisor for February 13 2015 at Investopedia
12:30PM  A Tactical Asset Allocation Horserace Between Two Thoroughbreds Yahoo Finance Contributors
11:36AM  The Huge Historical Bull Market Bias in International Stocks Yahoo Finance Contributors
11:15AM  What Do Low Interest Rates Mean For Stock Returns? Yahoo Finance Contributors
Feb-12-15 06:14PM  Presidents Day, negative before & after Yahoo Finance Contributors
05:35PM  This is the big one Yahoo Finance Contributors
04:41PM  All-Time Highs Yahoo Finance Contributors
04:00PM  OIL SPIKES, STOCKS SURGE: Here's what you need to know Business Insider
09:33AM  How I Measure Breadth & What It Says for Equities Right Now Yahoo Finance Contributors
08:31AM  Initial jobless claims rise more than expected Business Insider
08:30AM  Retail sales plunge in January Business Insider
Feb-11-15 11:32PM  "The wisdom of insecurity" in the stock market Yahoo Finance Contributors
04:29PM  Breadth Divergences: More Noise Than Useful Signal Of A Market Top Yahoo Finance Contributors
04:00PM  STOCKS GO NOWHERE: Here's what you need to know Business Insider
03:19PM  Perfect Storm for Stocks - Video Blog Zacks
02:59PM  What to Make of Apple Now That Its Market Cap Exceeds $700 Billion at TheStreet
02:41PM  Small-Cap ETFs Look for Breakouts ETF Trends
02:29PM  Top Anecdotal Signs of a Market Bubble Yahoo Finance Contributors
12:29PM  Stocks dont have to follow the market to make you money at MarketWatch
09:42AM  Why The Russell2000 Is About To Rally 10% Yahoo Finance Contributors
07:48AM  Stock and Oil Correlations are Decreasing Yahoo Finance Contributors
07:21AM  Tuesdays Notable Options Activity: Russell on the Mend Yahoo Finance Contributors
Feb-10-15 04:00PM  STOCKS RALLY, OIL FALLS: Here's what you need to know Business Insider
02:24PM  Ready to Return to Energy Stocks? Now May Be Time to Buy at TheStreet
11:33AM  S&P 500s slow-motion breakout attempt remains in play at MarketWatch
08:13AM  Stock breakout, Bond breakdown about to take place? Yahoo Finance Contributors
08:07AM  Bond and Stock Volatility Diverges Yahoo Finance Contributors
The investment seeks to track the investment results of an index composed of small-capitalization U.S. equities. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Russell 2000 Index (the "underlying index"), which measures the performance of the small-capitalization sector of the U.S. equity market.
DHR [NYSE]
Danaher Corp.
IndexS&P 500 P/E24.04 EPS (ttm)3.63 Insider Own1.50% Shs Outstand704.30M Perf Week-0.46%
Market Cap61.47B Forward P/E18.42 EPS next Y4.74 Insider Trans-3.56% Shs Float612.21M Perf Month5.35%
Income2.60B PEG2.56 EPS next Q0.94 Inst Own79.30% Short Float0.77% Perf Quarter4.80%
Sales19.91B P/S3.09 EPS this Y-4.20% Inst Trans0.19% Short Ratio1.70 Perf Half Y14.15%
Book/sh33.17 P/B2.63 EPS next Y9.17% ROA7.30% Target Price94.78 Perf Year13.88%
Cash/sh4.27 P/C20.45 EPS next 5Y9.40% ROE11.10% 52W Range70.04 - 88.10 Perf YTD1.83%
Dividend0.40 P/FCF20.96 EPS past 5Y17.40% ROI9.50% 52W High-0.93% Beta1.17
Dividend %0.46% Quick Ratio1.40 Sales past 5Y13.60% Gross Margin52.40% 52W Low24.61% ATR1.05
Employees66000 Current Ratio1.70 Sales Q/Q2.90% Oper. Margin17.20% RSI (14)56.37 Volatility0.93% 1.20%
OptionableYes Debt/Eq0.15 EPS Q/Q-17.10% Profit Margin13.00% Rel Volume0.79 Prev Close87.81
ShortableYes LT Debt/Eq0.15 EarningsJan 27 BMO Payout8.80% Avg Volume2.79M Price87.28
Recom1.70 SMA201.68% SMA502.48% SMA2009.52% Volume2,209,166 Change-0.60%
Jan-28-15Reiterated Stifel Buy $95 → $100
Jan-22-15Initiated UBS Buy $100
Dec-12-14Reiterated Barclays Overweight $86 → $93
Nov-26-14Reiterated FBR Capital Outperform $95 → $100
Nov-21-14Reiterated Argus Buy $86 → $92
Nov-12-14Upgrade FBR Capital Mkt Perform → Outperform $83 → $95
Oct-17-14Reiterated Barclays Overweight $79 → $86
Oct-16-14Reiterated ISI Group Buy $88.50 → $86.50
Sep-17-14Resumed Stifel Buy $90
Apr-09-14Upgrade ISI Group Buy → Strong Buy $86
Dec-31-13Reiterated FBR Capital Mkt Perform $73 → $83
Jul-10-13Reiterated ISI Group Buy $69.50 → $73
Apr-18-13Reiterated ISI Group Buy $70 → $68
Mar-25-13Reiterated Deutsche Bank Hold $64 → $70
Mar-18-13Reiterated FBR Capital Mkt Perform $54 → $63
Jan-30-13Reiterated UBS Buy $60 → $69
Jan-30-13Reiterated Barclays Equal Weight $23 → $27
Jan-29-13Reiterated ISI Group Buy $64 → $70
Jan-14-13Reiterated Barclays Overweight $57 → $60
Jan-07-13Upgrade ISI Group Neutral → Buy $61 → $64
Feb-27-15 10:12AM  EMCOR (EME) Lags Q4 Earnings, Shares Marginally Down - Analyst Blog Zacks
Feb-26-15 12:10PM  UTX's Sikorsky to Gain from UAE's Transport Modernization - Analyst Blog Zacks
10:10AM  Chicago Bridge (CBI) Q4 Earnings Beat, Revenues Up Y/Y - Analyst Blog Zacks
Feb-25-15 04:45PM  Danaher to Present at J.P. Morgan Aviation, Transportation and Industrials Conference PR Newswire
09:52AM  Dycom Q2 Earnings Crush Estimates, Revenues Beat & Up Y/Y - Analyst Blog Zacks
07:54AM  Early movers: LOW, DHR, HTZ, CHK, HPQ, SAM & more at CNBC
06:30AM  Danaher Increases Quarterly Dividend PR Newswire
06:08AM  DANAHER CORP /DE/ Files SEC form 10-K, Annual Report EDGAR Online
Feb-24-15 06:44PM  3M Boosts Core Filtration Business with Accretive Buy - Analyst Blog Zacks
Feb-14-15 12:05AM  What investors need to know about Boeings pension contribution Market Realist
Feb-12-15 04:45PM  Danaher To Present At Barclays Industrial Select Conference PR Newswire
Feb-04-15 06:11PM  Macquarie (MIC) to Acquire Bayonne Energy for $720M - Analyst Blog Zacks
05:08PM  GE Secures General Dynamics Orders Worth $100M - Analyst Blog Zacks
Feb-03-15 05:00PM  United Technologies (UTX) Hikes Quarterly Dividend by 8.5% - Analyst Blog Zacks
Feb-02-15 09:34AM  Pitney Bowes Earnings In-Line on Digital Commerce Business - Analyst Blog Zacks
Jan-27-15 10:53AM  Danaher (DHR) Q4 Earnings Meet, Revenues Miss Estimates - Analyst Blog Zacks
10:45AM  Danaher (DHR) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
08:00AM  Danaher Corp Earnings Call scheduled for 8:00 am ET today CCBN
07:34AM  Danaher (DHR) Q4 Earnings In-Line, Revenues Miss - Tale of the Tape Zacks
07:07AM  Q4 2014 Danaher Corp Earnings Release - 06:00 am ET CCBN
06:06AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
06:00AM  Danaher Reports Record Fourth Quarter And Full Year 2014 Results PR Newswire
Jan-26-15 03:33PM  What to Expect When Danaher (DHR) Reports Fourth-Quarter Earnings Tomorrow at TheStreet
10:43AM  Roper Q4 Earnings Beat on Sales Rise Across Segments - Analyst Blog Zacks
Jan-22-15 12:33PM  Coverage initiated on Danaher by UBS Briefing.com
Jan-13-15 12:06PM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
Jan-06-15 08:00AM  Danaher to Present at J.P. Morgan Healthcare Conference PR Newswire
Jan-02-15 11:51AM  Danaher's $2.6 Billion Asset Sale Just Caught the DOJ's Eye at TheStreet
Jan-01-15 10:20AM  Glenview Capital raises position in Endo International Market Realist
Dec-31-14 10:20AM  Glenview Capital opens new position in Danaher Market Realist
Dec-30-14 04:29PM  Glenview Capital starts new position in Realogy Holdings Market Realist
06:09AM  Can anything stop Danaher? optionMONSTER
05:30AM  Can Anything Stop Danaher After a Years-Long Streak? at TheStreet
Dec-29-14 02:15PM  HALFTIME FINAL TRADES 12/29/14 at CNBC
12:58PM  FMHR Final Trade: DHR, OCN, EWU & IWM CNBC
08:00AM  Danaher Schedules Fourth Quarter 2014 Earnings Conference Call PR Newswire
Dec-26-14 12:07PM  Sarat Sethi's 2015 tech picks CNBC
Dec-24-14 06:03AM  [video]Conglomerate Stocks: Year in Review and Where to Profit in 2015 at TheStreet
Dec-18-14 05:41PM  A Look at Thursday's Market Yahoo Finance Blogs
Dec-12-14 09:20AM  Danaher Acquires Nobel Biocare; Provides 2015 Guidance Zacks
Dec-11-14 08:03AM  Danaher Gives Rosy Earnings Outlook at The Wall Street Journal
06:00AM  Danaher Reaffirms 2014 Guidance and Initiates 2015 Outlook PR Newswire
01:00AM  Danaher Completes Acquisition Of Nobel Biocare PR Newswire
Dec-10-14 08:00AM  Danaher Announces Quarterly Dividend PR Newswire
Dec-09-14 07:58AM  The Global Dental Device Market to hit $12.7 Billion by 2020 Propelled by a Surge in Oral Diseases and Poor Oral Hygiene: ABMRG PR Newswire
Dec-08-14 06:00PM  Danaher To Webcast Investor And Analyst Meeting PR Newswire
Dec-03-14 05:30PM  NetScout Systems Files Preliminary Registration Statement on Form S-4 and Preliminary Proxy Statement for Special Shareholder Meeting Associated with the Acquisition of Danahers Communications Business Business Wire
Dec-02-14 06:47AM  Danaher sees complex bullish trade optionMONSTER
Nov-24-14 01:02PM  Three Stocks With More Opportunity Than Tyco at Barrons.com
Nov-13-14 09:00AM  Keyssa Promises to Let You 'Kiss' Your Cords Goodbye at BusinessWeek
07:37AM  [$$] Danaher Price Target Lifted to $95 at Barrons.com
Nov-12-14 11:16AM  Danaher Upgraded As Analyst Pushes Agilent Buyout at Investor's Business Daily
07:00AM  Danaher To Announce Future Change To Earnings Guidance At Baird Industrial Conference PR Newswire
Nov-07-14 08:02AM  Danaher to Webcast Investor and Analyst Meeting Thomson Reuters ONE
Nov-06-14 04:55PM  Daily Market Recap... Yahoo Finance Blogs
06:30AM  Horizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer Marketwired
Nov-03-14 12:08PM  3 Stocks Pushing The Industrial Industry Lower at TheStreet
Oct-28-14 07:26AM  Leica Biosystems to Acquire Devicor Medical Products, Inc. CNW Group
06:55AM  Leica Biosystems to Acquire Devicor Medical Products, Inc. PR Newswire
Oct-27-14 08:00AM  Photo Release -- VSS Monitoring Optimizer 2400 Redefines the Economics of Visibility Plane Systems for Enterprise Networks GlobeNewswire
Oct-23-14 05:00PM  Why Citadel Advisors increases its stake in Williams Companies Market Realist
01:00PM  Why Citadel Advisors almost doubles its position in Danaher Market Realist
09:00AM  Why Citadel Advisors raises its position in Baker Hughes Market Realist
Oct-22-14 01:04PM  DANAHER CORP /DE/ Financials EDGAR Online Financials
12:20PM  Must-know highlights of Citadel Advisors 2Q14 positions Market Realist
Oct-16-14 05:10PM  Danaher (DHR) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
03:47PM  Why Danaher (DHR) Stock Is Spiking Today at TheStreet
01:19PM  Danaher Stock Rebounds Despite Mixed Q3 Earnings at Investor's Business Daily
10:40AM  Danaher's Q3 Earnings In Line, Revenues Lag Estimates Zacks
08:00AM  Danaher Corp Earnings Call scheduled for 8:00 am ET today CCBN
07:07AM  Q3 2014 Danaher Corp Earnings Release - Before Market Open CCBN
06:44AM  [$$] Danaher Profit Rises at The Wall Street Journal
06:13AM  Danaher beats 3Q earnings expectations AP
06:00AM  Danaher Reports Record Third Quarter 2014 Results PR Newswire
05:59AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
05:59AM  DANAHER CORP /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
Oct-14-14 04:09PM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statemen EDGAR Online
03:25PM  Analysts See Trouble In NetScout Systems/Danaher Deal Benzinga
Oct-13-14 07:00PM  [video] Cramer: Stocks exposed to this are going lower at CNBC
06:00PM  Cramer's genuine rally checklist CNBC
11:23AM  Danaher to combine communications unit with NetScout Reuters
10:50AM  Can Danaher Corp. (DHR) Surprise this Earnings Season? Zacks
10:26AM  NetScout Bolsters Cyber Intelligence Business in $2.6 Billion Deal at TheStreet
09:00AM  NetScout Systems Inc to Acquire Danaher's Communications Business Call scheduled for 9:00 am ET today CCBN
08:19AM  Danaher to combine communications business with NetScout Reuters
08:03AM  Story Stocks from Briefing.com Briefing.com
07:17AM  NetScout to Buy Danaher Unit for $2.6 Billion at Bloomberg
07:14AM  NetScout buying Danaher's communications business AP
07:02AM  Danaher sells communications business to NetScout in $2.6 billion deal at MarketWatch
06:58AM  NetScout to buy Danaher's communications business for $2.6 bln Reuters
06:45AM  Danaher And NetScout Systems Announce Business Combination PR Newswire
Oct-08-14 11:23AM  [$$] Three Picks in Electrical Equipment at Barrons.com
Oct-03-14 08:22AM  BTIG Initiates Coverage On Danaher Corporation Benzinga
Sep-23-14 01:04PM  3 Industrial Goods Stocks Dragging The Sector Down at TheStreet
Sep-22-14 04:46PM  Danaher Schedules Third Quarter 2014 Earnings Conference Call Thomson Reuters ONE
Sep-15-14 09:32PM  [$$] Danaher Seeks Extra Bite With $2.1 Billion Swiss Dental Deal at The Wall Street Journal
06:53PM  Danaher, Nobel in $2.2 bil deal Investor's Business Daily
04:10PM  DANAHER CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
01:37PM  [$$] Danaher Clinches Swiss Dental Deal at The Wall Street Journal
11:10AM  Danaher Buying Swiss Dental Firm For $2.2 Billion at Investor's Business Daily
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; network monitoring, management, and optimization tools; and security solutions for communications and enterprise networks. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet management. The company's Life Sciences & Diagnostics segment provides various research and clinical tools for scientists to study cells and its components; and a range of analytical instruments, reagents, consumables, software, and services for hospitals, physician's offices, reference laboratories, and various critical care settings. Its Dental segment provides dental consumables, equipment, and services for the diagnosis, treatment, and prevention of disease and ailments of the teeth, gums, and supporting bone. Danaher Corporation's Industrial Technologies segment offers equipment, consumables, and software for consumer and industrial products; and electromechanical motion control solutions for the industrial automation and packaging markets. This segment also provides sensors and controls products instruments to manufacturing markets and electric utility industry; energetic material systems to systems integrators and prime contractors; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Raskas DanielSVP-Corporate DevelopmentFeb 26Sale87.794,179366,86216,662Feb 27 05:30 PM
Graham Jonathan PSenior VP & GCFeb 24Sale86.779,961864,33627,106Feb 25 08:04 PM
Raskas DanielSVP-Corporate DevelopmentFeb 20Option Exercise30.7356,0001,720,88081,808Feb 23 05:07 PM
Raskas DanielSVP-Corporate DevelopmentFeb 20Sale87.0356,0004,873,90425,808Feb 23 05:07 PM
EHRLICH DONALD JDirectorFeb 03Option Exercise28.168,000225,28095,635Feb 04 05:05 PM
EHRLICH DONALD JDirectorFeb 03Sale84.828,000678,56087,635Feb 04 05:05 PM
LICO JAMES AExecutive Vice PresidentFeb 02Option Exercise30.7398,0003,011,540246,606Feb 03 05:47 PM
LICO JAMES AExecutive Vice PresidentFeb 02Sale82.6498,0008,099,070148,606Feb 03 05:47 PM
COMAS DANIEL LEVP & CFOJan 28Option Exercise25.8575,0001,938,750193,695Jan 29 05:46 PM
COMAS DANIEL LEVP & CFOJan 28Sale84.5975,0006,344,503118,695Jan 29 05:46 PM
DITKOFF JAMES HSenior VP-Finance & TaxNov 20Sale82.353,606296,954172,948Nov 21 04:26 PM
LICO JAMES AExecutive Vice PresidentOct 31Sale80.3925,2382,028,885103,451Nov 04 05:58 PM
Graham Jonathan PSenior VP & GCOct 30Option Exercise37.0720,000741,40063,969Nov 03 05:18 PM
Graham Jonathan PSenior VP & GCOct 30Sale79.2720,0001,585,50043,969Nov 03 05:18 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 20Option Exercise30.7340,0001,229,20065,808Oct 21 05:05 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 20Sale74.6540,0002,986,12025,808Oct 21 05:05 PM
COMAS DANIEL LEVP & CFOOct 17Option Exercise25.8550,0001,292,500168,695Oct 21 05:04 PM
COMAS DANIEL LEVP & CFOOct 17Sale75.1050,0003,755,075118,695Oct 21 05:04 PM
LOHR WALTER GDirectorSep 04Option Exercise26.188,000209,440460,635Sep 04 06:31 PM
King WilliamSenior Vice PresidentAug 01Sale73.743,545261,40824,329Aug 04 07:38 AM
SCHWIETERS JOHN TDirectorMay 28Option Exercise26.188,000209,44019,752May 30 07:29 AM
SCHWIETERS JOHN TDirectorMay 28Sale78.738,000629,84011,752May 30 07:29 AM
Graham Jonathan PSenior VP & GCMay 12Sale75.009,973747,94531,569May 14 05:51 PM
COMAS DANIEL LEVP & CFOMay 02Sale73.3639,9422,930,06588,935May 06 05:54 PM
Joyce Thomas Patrick JREVP and CEO-DesignateMay 02Sale73.4223,1911,702,61479,954May 06 05:53 PM
Raskas DanielSVP-Corporate DevelopmentMay 01Sale73.4811,158819,90119,048May 05 05:40 PM
WY [NYSE]
Weyerhaeuser Co.
IndexS&P 500 P/E25.26 EPS (ttm)1.39 Insider Own0.10% Shs Outstand525.00M Perf Week-0.26%
Market Cap18.43B Forward P/E18.40 EPS next Y1.91 Insider Trans-15.05% Shs Float516.29M Perf Month-0.48%
Income784.00M PEG5.05 EPS next Q0.31 Inst Own84.30% Short Float2.14% Perf Quarter0.49%
Sales7.40B P/S2.49 EPS this Y70.70% Inst Trans-1.50% Short Ratio3.55 Perf Half Y4.59%
Book/sh10.11 P/B3.47 EPS next Y22.07% ROA12.50% Target Price38.25 Perf Year22.93%
Cash/sh3.01 P/C11.67 EPS next 5Y5.00% ROE28.40% 52W Range26.60 - 36.74 Perf YTD-1.35%
Dividend1.16 P/FCF141.79 EPS past 5Y28.50% ROI10.60% 52W High-4.43% Beta1.47
Dividend %3.30% Quick Ratio2.70 Sales past 5Y7.90% Gross Margin22.20% 52W Low32.00% ATR0.55
Employees12800 Current Ratio3.30 Sales Q/Q1.10% Oper. Margin18.50% RSI (14)47.95 Volatility1.34% 1.54%
OptionableYes Debt/Eq1.02 EPS Q/Q- Profit Margin24.10% Rel Volume0.74 Prev Close35.09
ShortableYes LT Debt/Eq1.02 EarningsJan 30 BMO Payout31.10% Avg Volume3.12M Price35.11
Recom2.20 SMA200.20% SMA50-1.15% SMA2006.32% Volume2,313,400 Change0.06%
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Jan-29-13Reiterated Argus Buy $33 → $36
Jan-28-13Downgrade RBC Capital Mkts Outperform → Sector Perform $30 → $31
Jan-16-13Reiterated BMO Capital Markets Market Perform $28.50 → $33
Jul-17-12Downgrade BMO Capital Markets Market Perform → Underperform
Jul-06-12Downgrade DA Davidson Buy → Neutral $27 → $23
Mar-05-12Upgrade BMO Capital Markets Underperform → Market Perform $33 → $36
Feb-06-12Reiterated BMO Capital Markets Underperform $16 → $20
Oct-31-11Upgrade Deutsche Bank Sell → Hold $19 → $19
Aug-12-11Upgrade RBC Capital Mkts Underperform → Sector Perform $18 → $18
Aug-10-11Upgrade UBS Sell → Neutral
Aug-05-11Upgrade DA Davidson Neutral → Buy $22 → $22
Aug-01-11Reiterated Barclays Capital Overweight $33 → $31
Jun-06-11Upgrade DA Davidson Underperform → Neutral
Feb-07-11Reiterated Deutsche Bank Hold $20 → $24
Feb-07-11Downgrade UBS Neutral → Sell $18 → $18
Feb-20-15 05:00PM  Simons, Bedient to Represent Weyerhaeuser at Upcoming Investor Conferences PR Newswire
01:04PM  WEYERHAEUSER CO Financials EDGAR Online Financials
Feb-17-15 10:28AM  Weyerhaeuser Gains on Housing Market Revival, Runs Risks - Analyst Blog Zacks
Feb-15-15 07:07PM  10-K for Weyerhaeuser Co. Company Spotlight
Feb-13-15 04:15PM  Weyerhaeuser Company Declares Dividend on Common Shares PR Newswire
Feb-11-15 07:00AM  Weyerhaeuser Company (WY): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-06-15 03:20PM  How a West Coast port closure would hurt the economy at MarketWatch
Feb-02-15 01:11PM  The Reincarnation of Bell Labs at Fortune
10:10AM  Company News for February 02, 2015 - Corporate Summary Zacks
Jan-30-15 04:25PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St EDGAR Online
04:10PM  Weyerhaeuser Announces Election of David Bozeman to Board of Directors PR Newswire
02:46PM  Weyerhaeuser (WY) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
12:40PM  Weyerhaeuser Q4 Earnings and Revenues Miss Estimates - Analyst Blog Zacks
07:57AM  Early movers: YHOO, FL, TYC, XRX, TSN & more at CNBC
07:07AM  Q4 2014 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
05:10AM  Weyerhaeuser misses Street 4Q forecasts AP
04:54AM  Weyerhaeuser (WY) Q4 Earnings and Revenues Lag Estimates - Tale of the Tape Zacks
03:05AM  Weyerhaeuser Reports Fourth Quarter, Full Year Results PR Newswire
Jan-29-15 02:46PM  What to Expect When Weyerhaeuser (WY) Reports Fourth-Quarter Earnings Tomorrow at TheStreet
08:58AM  Why Earnings Season Could Be Great for Weyerhaeuser (WY) - Tale of the Tape Zacks
Jan-28-15 08:04PM  Farallon Capital sells stake in Weyerhaeuser Co. Market Realist
02:00PM  Can Weyerhaeuser Beat Q4 Earnings on Housing Recovery? - Analyst Blog Zacks
06:05AM  Up to Speed: Peltz receives ammo in fight against DuPont (Video) at American City Business Journals
Jan-20-15 12:45PM  ETF Securities Branches out From Commodities ETFs ETF Trends
11:10AM  Will United Rentals (URI) Miss Earnings Estimates in Q4? - Analyst Blog Zacks
Jan-13-15 06:29PM  Washington's employers may soon face a legion of allied unions at American City Business Journals
01:22PM  Weyerhaeuser Announces Tax Treatment of 2014 Distributions PR Newswire
Jan-08-15 06:15PM  Weyerhauser to cut jobs in response to port slowdown at American City Business Journals
Dec-29-14 01:01PM  Weyerhaeuser to release fourth quarter earnings on Jan. 30 PR Newswire
Dec-22-14 04:56PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
Dec-21-14 08:30AM  5 Trade Ideas for Monday: Domino's, Conagra, Schlumberger, AmerisourceBergen & Weyerhaeuser Yahoo Finance Blogs
Dec-19-14 11:39AM  Farallon Capital starts new position in International Game Technology Market Realist
Nov-20-14 02:44PM  Wynn Resorts Probed on Money-Laundering Controls The Wall Street Journal
Nov-14-14 04:50PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
04:30PM  Weyerhaeuser Announces Leadership Changes for Cellulose Fibers, Wood Products PR Newswire
Nov-12-14 04:59PM  Get Ideas For Stock Buys, Sells In Mutual Fund Monthly Reports Investor's Business Daily
Nov-04-14 06:38PM  Boise Cascade Building Profit Ahead Of New-Home Cycle at Investor's Business Daily
Nov-03-14 07:08PM  10-Q for Weyerhaeuser Co. Company Spotlight
12:07PM  3 Materials & Construction Stocks Moving The Industry Upward at TheStreet
Oct-31-14 08:28PM  Weyerhaeuser (WY) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
10:47AM  [video]Weyerhaeuser Earnings Beat Wall Street Estimates on Timber at TheStreet
10:40AM  Weyerhaeuser Beats on Q3 Earnings, Posts Weak Outlook Zacks
07:50AM  Weyerhaeuser Profit Rises, Outlook Appears Soft at 24/7 Wall St.
07:07AM  Q3 2014 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
06:01AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
05:03AM  Weyerhaeuser beats Street 3Q forecasts AP
03:38AM  Weyerhaeuser reports higher third-quarter profit Reuters
03:05AM  Weyerhaeuser Reports Third Quarter Results PR Newswire
Oct-29-14 06:30PM  Will Weyerhaeuser (WY) Miss Earnings Estimates in Q3? Zacks
Oct-15-14 08:14PM  Weyerhaeuser Company Declares Dividend PR Newswire
Oct-14-14 09:45AM  Weyerhaeuser, Elizabeth Arden, Eni, SAP and Sanofi highlighted as Zacks Bull and Bear of the Day Zacks
01:00AM  Bull of the Day: Weyerhaeuser (WY) Zacks
Oct-06-14 01:03PM  3 Real Estate Stocks Dragging The Industry Down at TheStreet
Sep-25-14 02:35PM  Weyerhaeuser to release third quarter results on Oct. 31 PR Newswire
Sep-24-14 01:03PM  3 Stocks Boosting The Real Estate Industry Higher at TheStreet
Sep-19-14 05:16AM  Show of support for Weyerhaeuser optionMONSTER
12:29AM  Marty Whitman's Third Avenue Buys 2 Forest Products Companies Gurufocus
Sep-12-14 01:04PM  3 Stocks Dragging The Financial Sector Downward at TheStreet
Sep-08-14 07:00PM  Weyerhaeuser to hold Investor Meeting on Dec. 9 PR Newswire
06:25PM  Time to Buy the Farm? at The Wall Street Journal
Aug-27-14 04:14PM  Simons, Bedient to Represent Weyerhaeuser at Upcoming Financial Conferences PR Newswire
Aug-26-14 07:28PM  Weyerhaeuser to Move Its Headquarters to Downtown Seattle at Bloomberg
06:34PM  Weyerhaeuser Announces Plans to Move Headquarters to Seattle PR Newswire
10:30AM  Weyerhaeuser Reaches a New 52-Week High on Solid Q2 Earnings Zacks
Aug-15-14 10:40AM  Weyerhaeuser Hikes Dividend, To Buy back $700 Million Shares Zacks
Aug-14-14 03:14PM  Why Weyerhaeuser (WY) Stock Is Gaining Today at TheStreet
07:01AM  [$$] Weyerhaeuser Raises Dividend, Unveils Share Buyback at The Wall Street Journal
Aug-13-14 08:00PM  Weyerhaeuser increases dividend by 32% and announces $700 million share repurchase program PR Newswire
Aug-11-14 10:30AM  Norbord upbeat on Europe but sees no uptick in prices for now Reuters
10:30AM  Norbord upbeat on Europe but sees no uptick in prices for now (Aug 8) Reuters
Aug-08-14 12:12PM  Norbord upbeat on Europe but sees no uptick in prices for now Reuters
Aug-06-14 11:24AM  [video] Apache, AGCO are Deeply Undervalued Says Third Ave Value Manager at TheStreet
Aug-04-14 04:24PM  WEYERHAEUSER CO Files SEC form 10-Q, Quarterly Report EDGAR Online
01:03PM  3 Stocks Boosting The Real Estate Industry Higher at TheStreet
09:10AM  Will This Analyst Upgrade Help Weyerhauser (WY) Stock Today? at TheStreet
08:41AM  Weyerhaeuser upgraded by DA Davidson Briefing.com
Aug-01-14 10:40AM  Weyerhaeuser Company Posts Upbeat Q2 Earnings, Revenues Lag Zacks
07:30AM  Weyerhaeuser profit beats on strong wood product sales Reuters
07:07AM  Q2 2014 Weyerhaeuser Co. Earnings Release - Before Market Open CCBN
06:05AM  [$$] Weyerhaeuser Earnings Rise at The Wall Street Journal
06:01AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
03:22AM  Weyerhaeuser quarterly profit rises 43 pct Reuters
03:00AM  Weyerhaeuser Reports Second Quarter Results PR Newswire
Jul-30-14 04:50PM  Will Weyerhaeuser (WY) Beat Earnings Estimates This Quarter? Zacks
Jul-28-14 01:03PM  3 Stocks Improving Performance Of The Real Estate Industry at TheStreet
Jul-24-14 02:07PM  Weyerhaeuser and DuPont Pioneer Enter Technology License Agreement PR Newswire
Jul-21-14 04:43PM  [video] Barse likes Weyerhaeuser & BNY Mellon at CNBC
Jul-11-14 08:15AM  Weyerhaeuser Joins the 5 Most Shorted NYSE Stocks at 24/7 Wall St.
Jul-10-14 06:28PM  Is Bigger Better For Builder TRI Pointe? Investor's Business Daily
02:54PM  Weyerhaeuser Will Likely Increase Its Dividend In 2014 at Seeking Alpha
11:29AM  TRI Pointe Appears Compelling After Absorbing Weyerhaeuser's Homebuilder at Seeking Alpha
Jul-09-14 04:47PM  WEYERHAEUSER CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:30PM  Weyerhaeuser Announces Final Proration Factor of 28.55 Percent for Shares Tendered in Exchange Offer PR Newswire
03:26PM  Break Up Bonanza at Forbes
Jul-08-14 12:47PM  Why TRI Pointe Homes (TPH) Stock Is Climbing Today at TheStreet
11:40AM  Weyerhaeuser Closes WRECO Spilt-Off to Tri Ponte Zacks
08:00AM  TRI Pointe Homes Closes $2.8 Billion Merger with Weyerhaeuser Real Estate Company Business Wire
Jul-07-14 05:59PM  With Merger Closed, TRI Pointe Homes to Focus on Expansion, New Services at The Wall Street Journal
01:35PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Directors or Princi EDGAR Online
01:03PM  3 Stocks Pushing The Real Estate Industry Downward at TheStreet
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Federal Way, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Merle Denise MSenior Vice PresidentFeb 04Option Exercise23.2911,559269,26027,743Feb 05 05:27 PM
Hunter Rhonda DSr. Vice PresidentFeb 04Option Exercise21.198,441178,84337,029Feb 05 05:27 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 04Option Exercise26.7131,587843,83568,372Feb 05 05:35 PM
Hunter Rhonda DSr. Vice PresidentFeb 04Sale35.268,441297,63428,588Feb 05 05:27 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 04Sale35.2631,5871,113,77336,785Feb 05 05:35 PM
Merle Denise MSenior Vice PresidentFeb 04Sale35.4211,559409,47116,184Feb 05 05:27 PM
Bedient Patricia MExecutive Vice President & CFONov 10Option Exercise23.9215,017359,237173,729Nov 12 12:16 PM
Bedient Patricia MExecutive Vice President & CFONov 10Sale34.5015,017518,087158,712Nov 12 12:16 PM
Bedient Patricia MExecutive Vice President & CFONov 05Option Exercise23.9214,182339,262172,894Nov 06 07:46 PM
Bedient Patricia MExecutive Vice President & CFONov 05Sale34.5014,182489,280158,712Nov 06 07:46 PM
Hunter Rhonda DSr. Vice PresidentAug 27Option Exercise14.8012,242181,21840,266Aug 28 07:33 PM
Hunter Rhonda DSr. Vice PresidentAug 27Sale34.2112,242418,77628,024Aug 28 07:33 PM
Orser Peter MSubsidiary Pres.Jun 05Option Exercise20.0066,4141,328,190133,991Jun 06 06:50 PM
Orser Peter MSubsidiary Pres.Jun 05Sale31.3052,0001,627,59581,991Jun 06 06:50 PM
MCDADE SANDY DSenior Vice PresidentMar 07Option Exercise14.8015,427228,366105,353Mar 10 05:13 PM
MCDADE SANDY DSenior Vice PresidentMar 07Sale29.9215,427461,51089,926Mar 10 05:13 PM
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E50.64 EPS (ttm)2.40 Insider Own0.20% Shs Outstand798.70M Perf Week-1.54%
Market Cap97.07B Forward P/E19.27 EPS next Y6.31 Insider Trans-30.10% Shs Float796.60M Perf Month2.15%
Income2.00B PEG1.99 EPS next Q1.07 Inst Own83.60% Short Float1.38% Perf Quarter9.42%
Sales7.67B P/S12.65 EPS this Y42.30% Inst Trans0.85% Short Ratio1.98 Perf Half Y28.28%
Book/sh7.21 P/B16.86 EPS next Y30.60% ROA13.80% Target Price137.54 Perf Year50.35%
Cash/sh8.59 P/C14.15 EPS next 5Y25.50% ROE38.70% 52W Range66.85 - 125.45 Perf YTD8.64%
Dividend- P/FCF- EPS past 5Y23.60% ROI21.20% 52W High-3.12% Beta1.05
Dividend %- Quick Ratio6.10 Sales past 5Y23.30% Gross Margin95.00% 52W Low81.80% ATR2.98
Employees5100 Current Ratio6.30 Sales Q/Q18.80% Oper. Margin33.50% RSI (14)54.72 Volatility1.83% 2.68%
OptionableYes Debt/Eq1.19 EPS Q/Q196.00% Profit Margin26.10% Rel Volume0.77 Prev Close123.35
ShortableYes LT Debt/Eq1.17 EarningsJan 29 BMO Payout0.00% Avg Volume5.56M Price121.53
Recom1.80 SMA201.63% SMA503.37% SMA20023.02% Volume4,269,001 Change-1.48%
Feb-25-15Reiterated Argus Buy $130 → $155
Dec-09-14Reiterated UBS Buy $112 → $130
Dec-09-14Reiterated Argus Buy $102 → $130
Oct-24-14Reiterated Deutsche Bank Buy $115 → $134
Sep-29-14Reiterated RBC Capital Mkts Outperform $100 → $115
Aug-06-14Reiterated RBC Capital Mkts Outperform $95 → $100
Apr-25-14Reiterated Summer Street Research Buy $205 → $184
Mar-19-14Reiterated Summer Street Research Buy $180 → $205
Feb-27-14Reiterated UBS Buy $200 → $209
Jan-28-14Reiterated Deutsche Bank Buy $170 → $190
Jan-14-14Reiterated Brean Capital Buy $191 → $233
Dec-05-13Upgrade UBS Neutral → Buy $163 → $200
Oct-28-13Reiterated Argus Buy $175
Oct-25-13Reiterated Barclays Overweight $158 → $173
Jul-26-13Reiterated Cantor Fitzgerald Buy $156
Jul-26-13Reiterated Barclays Overweight $132 → $158
Jul-26-13Reiterated Argus Hold $160
Jul-17-13Reiterated RBC Capital Mkts Outperform $130 → $145
Jun-13-13Upgrade Argus Hold → Buy $140
Apr-26-13Reiterated Barclays Overweight $113 → $132
Feb-27-15 01:04PM  CELGENE CORP /DE/ Financials EDGAR Online Financials
09:30AM  The Zacks Analyst Blog Highlights: Pharmacyclics, Celgene, Amgen and Regeneron - Press Releases Zacks
Feb-26-15 07:25PM  Multiple Myeloma: A Growing Market For Treatment at Investopedia
11:07AM  Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog Zacks
09:56AM  Medivation Tops Q4 Views On Strong Xtandi Results at Investor's Business Daily
Feb-25-15 08:00AM  Psoriatic Arthritis Patients "pSAY YES!" to a Different Approach to Disease Management PR Newswire
Feb-24-15 02:27PM  Brain-Altering Devices May Supplant Drugs -- And Pharma Is OK With That at Forbes
12:56PM  In The Book Of Life, A Second Map Is Established at Forbes
10:04AM  United Therapeutics Blood Pressure Drug Lifts Q4 at Investor's Business Daily
08:00AM  ABRAXANE® Now Reimbursed in Italy as a First-Line Treatment of Adult Patients with Metastatic Pancreatic Cancer Business Wire
06:00AM  [video]'Mad Money' Lightning Round: Buy Enbridge Energy Partners at TheStreet
Feb-23-15 07:58PM  Gilead Sciences, Inc., Amgen, Inc., Biogen Idec Inc Among Billionaires 5 Hottest Biotech Picks at Insider Monkey
06:50PM  Lightning Round: Don't listen to this CEO at CNBC
06:20PM  Celgene Gains on Label Expansion of Revlimid in the EU - Analyst Blog Zacks
06:00PM  Blowing bubbles or smoke: Cramer's take on Nasdaq CNBC
04:49PM  Monday's Market Recap Yahoo Finance Contributors
12:18PM  Nasdaq: Why this time is different CNBC
07:30AM  6 Ways to Trade Celgene this Week Yahoo Finance Contributors
04:40AM  ADDING MULTIMEDIA REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant Business Wire
Feb-22-15 07:07PM  10-K for Celgene Corp. Company Spotlight
Feb-20-15 05:01PM  Celgene (CELG) Stock Gained Today on European Commission Approval of Revlimid at TheStreet
02:30PM  Celgene Up on Hematology Drug Revlimid's Label Expansion - Analyst Blog Zacks
01:21PM  Short-term bulls betting on Celgene optionMONSTER
11:59AM  Celgene Flirting With All-Time Highs Benzinga
07:19AM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events EDGAR Online
03:30AM  REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant Business Wire
Feb-19-15 09:00AM  ADDING MULTIMEDIA FDA Expands Indication for REVLIMID® (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma Business Wire
08:30AM  Celgene Corporation to Webcast at Upcoming Investor Conferences Business Wire
Feb-18-15 03:31PM  Is Revlimid Becoming a Catch-All Cancer Drug? at 24/7 Wall St.
02:30PM  Street Talk: CELG, RH, CTL, RAX & MNTA CNBC
11:00AM  U.S. FDA approves new use for Celgene's cancer drug Revlimid Reuters
09:37AM  FDA Expands Indication for REVLIMID® (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma Business Wire
07:54AM  Analysts' Actions: Celgene, Legg Mason, Rackspace, Williams-Sonoma TheStreet
Feb-16-15 03:30PM  Will Agios (AGIO) Surprise Estimates This Earnings Season? - Analyst Blog Zacks
Feb-13-15 06:33AM  Inside Celgene's ecosystem : CEO CNBC
06:00AM  'Mad Money' Lightning Round: Just Say No to Conoco Stock at TheStreet
Feb-12-15 05:37PM  Stock Therapy: Hedge funds target biotech CNBC
08:38AM  Brookdale Senior Living in final phase of strategic transactions Market Realist
Feb-11-15 04:59PM  Celgene Up on Abraxane Getting Positive Recommendation - Analyst Blog Zacks
04:22PM  Stocks End Mixed: Molina Healthcare Rises Again at Investor's Business Daily
11:47AM  Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analyst Blog Zacks
08:02AM  Top Performing Large Cap Funds Makes Some Headway at Investor's Business Daily
06:00AM  [video]'Mad Money' Lightning Round: Stop Fretting and Buy, Buy, Buy Sirius XM at TheStreet
Feb-10-15 06:00PM  Cramer: You need to see this Apple news CNBC
02:00AM  Celgene Announces Positive Recommendation by Scottish Medicines Consortium (SMC) for ABRAXANE® (Nab-Paclitaxel) in combination with Gemcitabine1 for Patients with Metastatic Pancreatic Cancer Business Wire
Feb-06-15 06:29PM  No Deceleration Here: 14 Stocks With Accelerating Profits at Investor's Business Daily
06:00PM  Cramer's earnings plan: MAS, CVS & more CNBC
03:19PM  Drug price battles CNBC
Feb-05-15 04:20PM  OncoMed Starts Dosing in Non-Small Cell Lung Cancer Study - Analyst Blog Zacks
09:30AM  The Zacks Analyst Blog Highlights: Amgen, Biogen, Celgene, AbbVie and Gilead - Press Releases Zacks
Feb-04-15 06:00PM  Cramer: The 'Scarface' market CNBC
05:46PM  Best biotech plays CNBC
02:26PM  Oil, Earnings, Strong U.S. Dollar Keeping Stocks in 'No Man's Land' at TheStreet
12:36PM  Safe biotech plays CNBC
11:47AM  Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog Zacks
09:38AM  Pisani's market open: 4 market stressors CNBC
09:22AM  Cramer's Mad Dash: GILD & CMG CNBC
Feb-03-15 06:15PM  Repros Files for Androxal in the U.S. for Hypogonadism - Analyst Blog Zacks
04:55PM  Eli Lilly/Boehringer Type II Diabetes Drug Gains FDA Nod - Analyst Blog Zacks
04:49PM  Paying Dividends: Gilead Initiates First Quarterly Payout at Barrons.com
01:30PM  Biotechs Weigh On Nasdaq; McGraw Hill Rallies at Investor's Business Daily
Feb-02-15 10:38AM  Jefferies Raises Price Target On Celgene, Says It Was 'Too Pessimistic' Benzinga
Feb-01-15 12:01AM  New Jersey Governor heads to UK for trade, politics, soccer Reuters
Jan-30-15 05:25PM  Celldex/Bristol-Myers Initiate Phase I/II Solid Tumor Study - Analyst Blog Zacks
04:54PM  Intercept Pharmaceuticals' OCA Now Breakthrough Therapy - Analyst Blog Zacks
12:15PM  Upside play in biotech space CNBC
12:05PM  Celgene's EPS Contain 'Few Surprises,' Baird Says Benzinga
11:40AM  Biogen Tops Q4 Earnings, Provides Strong Outlook for 2015 - Analyst Blog Zacks
10:54AM  Eli Lilly's 4Q Earnings Beat, Revenue Outlook Lowered - Analyst Blog Zacks
10:50AM  AbbVie Q4 Earnings Beat Expectations on Humira Strength - Analyst Blog Zacks
10:20AM  SurModics Beats on Q1 Earnings, Reaffirms 2015 Guidance - Analyst Blog Zacks
07:33AM  Embracing 'disruptive' technology: Celgene CEO CNBC
07:05AM  Reinventing pharma's next big frontier: Pro CNBC
06:00AM  Obama's $215 Million DNA Sequencing Project Is A Great Idea at Forbes
Jan-29-15 05:28PM  Celgene (CELG) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
04:35PM  Incyte's Phase III RESPONSE Data on Jakafi Published - Analyst Blog Zacks
04:20PM  Alexion Misses on Q4 Earnings, 2015 Outlook Disappoints - Analyst Blog Zacks
04:19PM  Salix Financial Results Need Correcting: Audit Committee - Analyst Blog Zacks
04:07PM  BioDelivery Signs Agreement with Meda for Onsolis - Analyst Blog Zacks
01:48PM  Alexion Pharmaceuticals: When Tax Rate Trumps FX at Barrons.com
11:52AM  Celgene says 2015 off to strong start; key growth drivers in place Reuters
10:51AM  Celgene Q4 Earnings & Revenues In Line, Revlimid Sales Up - Analyst Blog Zacks
10:45AM  Is Celgenes Outlook Good Enough for Investors? at 24/7 Wall St.
10:10AM  Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog Zacks
09:09AM  Celgene tops 4Q profit forecasts AP
08:59AM  Celgene (CELG) Q4 Earnings In Line with Estimates, Shares Up - Tale of the Tape Zacks
07:56AM  Celgene Revenue Rises on Cancer Drug Sales at The Wall Street Journal
07:34AM  CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
07:30AM  Celgene Reports Fourth Quarter and Full Year 2014 Operating and Financial Results Business Wire
07:07AM  Q4 2014 Celgene Corp Earnings Release - Before Market Open CCBN
Jan-28-15 06:25PM  Synageva Starts Dosing in Phase I/II Study for Sanfilippo B - Analyst Blog Zacks
10:00AM  Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog Zacks
Jan-27-15 06:55PM  Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog Zacks
06:30PM  The Medicines Co. Gets CHMP Recommendation for 3 Drugs - Analyst Blog Zacks
04:45PM  Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog Zacks
10:19AM  Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog Zacks
08:30AM  Celgene Corporation to Webcast at Upcoming Investor Conferences Business Wire
Jan-26-15 12:00PM  TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog Zacks
08:02AM  Apple, Facebook Lead This Week's IBD 50 Earnings at Investor's Business Daily
Jan-24-15 08:02AM  Apple, Facebook Lead Top IBD 50 Earnings This Week at Investor's Business Daily
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. The company's commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancers; and POMALYST/IMNOVID for the treatment of multiple myeloma. Its commercial stage products also comprise THALOMID for the patients with multiple myeloma and for the acute treatment of the cutaneous manifestations of erythema nodosum leprosum; ISTODAX to treat cutaneous T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. The company's pre clinical and clinical stage products consist of OTEZLA for the treatment of psoriatic arthritis, psoriasis, and ankylosing spondylitis; CC-122 and CC-220 to treat hematological and solid tumor cancers; cellular therapies, such as PDA-001 and PDA-002 for Crohn's and peripheral arterial diseases; CC-486, to treat MDS, AML, and solid tumors; Sotatercept and ACE-536 for the treatment of anemia in patients with rare blood disorders; CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers; and CC-292 for the treatment of chronic lymphocytic leukemia and lymphomas. It has strategic drug discovery collaboration with Abide Therapeutics to enhance the treatment paradigm for patients with immune disorders; strategic collaboration with Sutro Biopharma, Inc. to discover and develop antibodies and antibody drug conjugates; and strategic alliance with Forma Therapeutics. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
KAPLAN GILLADirectorFeb 26Option Exercise8.4715,000127,02094,508Feb 27 04:14 PM
KAPLAN GILLADirectorFeb 26Sale122.8915,0001,843,35079,508Feb 27 04:14 PM
CASEY MICHAEL DDirectorFeb 25Option Exercise8.4715,000127,02015,000Feb 27 04:13 PM
CASEY MICHAEL DDirectorFeb 25Sale123.1915,0001,847,7900Feb 27 04:13 PM
Alles Mark JSee RemarksFeb 12Option Exercise45.4327,5051,249,653101,145Feb 17 04:44 PM
KARSEN PERRY Asee remarksFeb 11Option Exercise37.5227,8961,046,52098,013Feb 13 05:07 PM
KARSEN PERRY Asee remarksFeb 11Sale120.1227,8963,350,72870,117Feb 13 05:07 PM
Alles Mark JSee RemarksFeb 06Option Exercise41.75107,8594,503,114174,001Feb 10 06:46 PM
Alles Mark JSee RemarksFeb 06Sale120.68117,09914,131,15656,902Feb 10 06:46 PM
MARIO ERNESTDirectorFeb 03Option Exercise27.697,666212,272137,024Feb 04 04:11 PM
STEIN LAWRENCE VSee RemarksJan 15Option Exercise39.3324,124948,79730,858Jan 20 04:11 PM
STEIN LAWRENCE VSee RemarksJan 15Sale120.0126,6663,200,2534,192Jan 20 04:11 PM
KAPLAN GILLADirectorJan 02Option Exercise16.2145,536738,25245,536Jan 06 04:17 PM
KAPLAN GILLADirectorJan 02Sale113.4745,5365,167,1340Jan 06 04:17 PM
KARSEN PERRY Asee remarksDec 30Option Exercise29.7523,334694,18774,744Jan 02 04:01 PM
KARSEN PERRY Asee remarksDec 30Sale113.3719,2732,184,98055,471Jan 02 04:01 PM
Daniel Thomas Osee remarksDec 15Option Exercise29.7530,000892,50075,400Dec 17 04:03 PM
Daniel Thomas Osee remarksDec 15Sale115.0630,0003,451,87245,400Dec 17 04:03 PM
KAPLAN GILLADirectorDec 08Option Exercise7.0915,000106,38894,508Dec 10 04:41 PM
KAPLAN GILLADirectorDec 08Sale118.2015,0001,773,00079,508Dec 10 04:41 PM
Smith Scott AndrewSee RemarksNov 30Option Exercise0.006,67006,670Dec 02 04:14 PM
Daniel Thomas Osee remarksNov 24Option Exercise0.0033,818079,218Nov 26 04:32 PM
Daniel Thomas Osee remarksNov 24Sale110.2733,8183,729,11145,400Nov 26 04:32 PM
KARSEN PERRY Asee remarksNov 12Option Exercise32.9032,0741,055,39190,830Nov 14 04:13 PM
KARSEN PERRY Asee remarksNov 12Sale107.2339,4204,227,00751,410Nov 14 04:13 PM
HUGIN ROBERT Jsee remarksNov 03Option Exercise14.35744,40010,683,7501,769,158Nov 04 04:07 PM
HUGIN ROBERT Jsee remarksNov 03Sale106.68158,00016,855,4401,177,300Nov 04 04:07 PM
MARIO ERNESTDirectorOct 27Sale102.85100,00010,284,630129,358Oct 29 04:09 PM
CASEY MICHAEL DDirectorOct 24Option Exercise7.0915,000106,38815,000Oct 28 04:08 PM
CASEY MICHAEL DDirectorOct 24Sale102.9415,0001,544,1080Oct 28 04:08 PM
KAPLAN GILLADirectorSep 08Option Exercise7.2530,000217,425109,508Sep 10 05:14 PM
KAPLAN GILLADirectorSep 08Sale93.7330,0002,811,90079,508Sep 10 05:14 PM
KARSEN PERRY Asee remarksAug 04Option Exercise28.1646,4501,308,03297,860Aug 05 04:14 PM
KARSEN PERRY Asee remarksAug 04Sale87.5539,1043,423,43458,756Aug 05 04:14 PM
BARKER RICHARD WDirectorJul 25Option Exercise31.8018,600591,38723,562Jul 28 04:46 PM
BARKER RICHARD WDirectorJul 25Sale87.0317,6001,531,6585,962Jul 28 04:46 PM
MARIO ERNESTDirectorJul 24Option Exercise27.695,000138,450229,358Jul 28 04:45 PM
MARIO ERNESTDirectorJun 15Option Exercise0.003,1000111,837Jun 16 06:57 PM
CASEY MICHAEL DDirectorJun 15Option Exercise0.001,03403,100Jun 16 06:53 PM
DRAKE RODMAN LDirectorJun 15Option Exercise0.001,034026,180Jun 16 06:54 PM
BARKER RICHARD WDirectorJun 13Option Exercise0.001,03302,790Jun 16 06:52 PM
DRAKE RODMAN LDirectorJun 13Option Exercise0.00516025,146Jun 16 06:54 PM
CASEY MICHAEL DDirectorJun 13Option Exercise0.001,03302,066Jun 16 06:53 PM
Friedman Michael ADirectorJun 13Option Exercise0.001,03303,099Jun 16 06:55 PM
KAPLAN GILLADirectorJun 13Option Exercise0.001,033039,754Jun 16 06:56 PM
LOUGHLIN JAMES JDirectorJun 13Option Exercise0.001,03308,509Jun 16 06:56 PM
MARIO ERNESTDirectorJun 13Option Exercise0.001,0330108,737Jun 16 06:57 PM
MARIO ERNESTDirectorJun 12Option Exercise0.001,0330107,704Jun 16 06:57 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.001,03307,476Jun 16 06:56 PM
KAPLAN GILLADirectorJun 12Option Exercise0.001,033038,721Jun 16 06:56 PM
Friedman Michael ADirectorJun 12Option Exercise0.001,03302,066Jun 16 06:55 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.001,03301,033Jun 16 06:53 PM
DRAKE RODMAN LDirectorJun 12Option Exercise0.001,033024,630Jun 16 06:54 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.001,03302,066Jun 16 06:52 PM
KAPLAN GILLADirectorJun 09Option Exercise13.6815,000205,12552,688Jun 11 04:02 PM
CASEY MICHAEL DDirectorJun 09Option Exercise13.6815,000205,12515,000Jun 11 04:01 PM
KAPLAN GILLADirectorJun 09Sale161.6215,0002,424,29437,688Jun 11 04:02 PM
FOUSE JACQUALYN Asee remarksMay 02Option Exercise0.007,800025,589May 05 06:19 PM
HUGIN ROBERT Jsee remarksMay 02Option Exercise0.0030,0000540,434May 05 06:18 PM
KARSEN PERRY Asee remarksMay 01Option Exercise59.5011,667694,18737,627May 05 06:16 PM
KARSEN PERRY Asee remarksMay 01Sale146.7811,9221,749,91125,705May 05 06:16 PM
DRAKE RODMAN LDirectorApr 30Option Exercise38.431,00038,43023,597May 02 04:47 PM
CELGENE CORP /DE/10% OwnerApr 14Buy7.00714,2865,000,0022,386,760Apr 15 04:01 PM
MARIO ERNESTDirectorApr 07Option Exercise55.386,000332,280106,671Apr 08 04:44 PM
HUGIN ROBERT Jsee remarksMar 13Option Exercise30.9095,2042,941,921568,868Mar 14 04:03 PM
CASEY MICHAEL DDirectorMar 04Option Exercise10.9712,770140,08712,770Mar 05 04:19 PM
CASEY MICHAEL DDirectorMar 04Sale162.3312,7702,072,9540Mar 05 04:19 PM
KARSEN PERRY Asee remarksMar 03Sale159.052,408382,99225,960Mar 05 04:20 PM
CASEY MICHAEL DDirectorFeb 28Option Exercise10.972,23024,4632,230Mar 04 04:08 PM
CASEY MICHAEL DDirectorFeb 28Sale164.282,230366,3350Mar 04 04:08 PM
CVS [NYSE]
CVS Health Corporation
IndexS&P 500 P/E26.16 EPS (ttm)3.97 Insider Own0.10% Shs Outstand1.13B Perf Week1.14%
Market Cap116.88B Forward P/E17.75 EPS next Y5.85 Insider Trans-39.06% Shs Float1.12B Perf Month4.29%
Income4.65B PEG1.78 EPS next Q1.08 Inst Own87.40% Short Float1.98% Perf Quarter15.45%
Sales139.37B P/S0.84 EPS this Y5.90% Inst Trans-1.22% Short Ratio4.75 Perf Half Y31.68%
Book/sh33.21 P/B3.13 EPS next Y13.43% ROA6.30% Target Price110.77 Perf Year46.01%
Cash/sh2.24 P/C46.47 EPS next 5Y14.70% ROE12.20% 52W Range70.68 - 104.48 Perf YTD8.23%
Dividend1.40 P/FCF24.80 EPS past 5Y9.30% ROI10.30% 52W High-0.58% Beta1.05
Dividend %1.35% Quick Ratio0.70 Sales past 5Y7.20% Gross Margin18.20% 52W Low46.97% ATR1.37
Employees137800 Current Ratio1.40 Sales Q/Q13.00% Oper. Margin6.30% RSI (14)63.37 Volatility0.96% 1.42%
OptionableYes Debt/Eq0.34 EPS Q/Q9.50% Profit Margin3.30% Rel Volume0.81 Prev Close104.17
ShortableYes LT Debt/Eq0.31 EarningsFeb 10 BMO Payout27.60% Avg Volume4.68M Price103.87
Recom1.80 SMA202.03% SMA505.10% SMA20022.17% Volume3,795,920 Change-0.29%
Feb-13-15Reiterated Deutsche Bank Hold $100 → $109
Feb-11-15Reiterated RBC Capital Mkts Outperform $108 → $115
Feb-11-15Reiterated Mizuho Buy $103 → $113
Feb-11-15Reiterated Argus Buy $104 → $114
Dec-18-14Reiterated Argus Buy $95 → $105
Dec-17-14Reiterated RBC Capital Mkts Outperform $96 → $103
Nov-12-14Reiterated Mizuho Buy $85 → $103
Nov-05-14Reiterated RBC Capital Mkts Outperform $86 → $96
Nov-05-14Reiterated Argus Buy $85 → $95
Aug-06-14Reiterated RBC Capital Mkts Outperform $76 → $86
Aug-06-14Reiterated Mizuho Buy $81 → $85
Aug-06-14Reiterated Argus Buy $83 → $85
Aug-05-14Reiterated ISI Group Strong Buy $86 → $88
May-19-14Initiated Standpoint Research Strong Sell $62
May-05-14Reiterated Barclays Overweight $74 → $85
Apr-04-14Reiterated Argus Buy $77 → $83
Jan-22-14Upgrade ISI Group Buy → Strong Buy
Dec-19-13Reiterated RBC Capital Mkts Outperform $71 → $76
Dec-19-13Reiterated Mizuho Buy $74 → $81
Dec-19-13Reiterated FBR Capital Outperform $72 → $80
Feb-27-15 06:02PM  Final Glance: Drug Benefits companies AP
01:26PM  Midday Glance: Drugstore companies AP
01:26PM  Midday Glance: Drug Benefits companies AP
12:49PM  Harley-Davidson is 1 of 3 shorts to ride now: Lamensdorf Yahoo Finance
12:00PM  CVS Health To Present At Barclays Global Healthcare Conference PR Newswire
11:48AM  Horizon Pharma Soars On Q4 Beat, Guidance Raise at Investor's Business Daily
11:10AM  Early Glance: Drugstore companies AP
11:10AM  Early Glance: Drug Benefits companies AP
Feb-26-15 06:03PM  Final Glance: Drugstore companies AP
11:59AM  Catamaran EPS Tops, But Stock Falls On Weak Guidance at Investor's Business Daily
10:58AM  Moody's Upgrades Three and Affirms Three Classes of FULB 1998-C2 at Moody's
Feb-23-15 06:05PM  Apple has Apple Pay hurdles to jump Market Realist
12:01AM  Regeneron Shares Reach Full Valuation at Barrons.com
Feb-20-15 09:00AM  Don't underestimate the power of Hispanic shoppers at CNBC
Feb-18-15 01:04PM  CVS HEALTH CORP Financials EDGAR Online Financials
10:41AM  Best hedge funds in Q4 CNBC
06:34AM  Chairs: CVS' red flag on costly drugs CNBC
Feb-17-15 07:06PM  Jim Cramer's 'Mad Money' Recap: What's Hot and Fashionable in Stocks at TheStreet
05:55PM  CVS urges cost controls for new cholesterol drugs Reuters
04:59PM  CVS girds for battle over cholesterol drugs at MarketWatch
02:58PM  UPDATE 1-CVS urges cost controls for new cholesterol, specialty drugs Reuters
02:28PM  CNBC update: A-Rod's apology & a Tesla for everyone CNBC
12:30PM  CNBC noon update: Greece-Germany tensions CNBC
09:54AM  CVS says new cholesterol drugs could cost U.S. $150 bln/year Reuters
09:00AM  CVS Health Raises Concerns about the Potential Impact of New Class of Cholesterol Drugs on the Health Care System PR Newswire
Feb-16-15 12:20PM  CVS Health To Present At RBC Capital Markets Healthcare Conference PR Newswire
Feb-13-15 06:00PM  Making Money With Charles Payne: 02/13/15 at Fox Business
11:53AM  Quotes from this week's earnings calls Yahoo Finance Contributors
09:22AM  The 10 Most Overpaid CEOs Running Multi-Billion Dollar Companies at TheStreet
08:48AM  Cigarettes & health do not mix: CVS CEO CNBC
08:06AM  CVS Anti-Tobacco Stance Boosts Hospital, Health System Deals at Forbes
Feb-12-15 07:40PM  Moody's Upgrades Two and Affirms Three Classes of LBUBS 2000-C4 at Moody's
07:07PM  10-K for CVS Caremark Corp. Company Spotlight
02:36PM  How CVS turned its cigarette ban into a strategic weapon Business Insider
11:40AM  Rite Aid (RAD) Jumps 6.6% on TPG's EnvisionRx Buyout - Analyst Blog Zacks
09:25AM  Rite Aid (RAD) Worth Watching: Stock Moves 6.6% Higher - Tale of the Tape Zacks
Feb-11-15 05:50PM  Rite Aid Stock Soars, Steps Up Competition With CVS at Investor's Business Daily
04:22PM  Jim Cramer Explains Why Rite Aid (RAD) is Now a Growth Stock After Envision Acquisition at TheStreet
01:37PM  Rite Aid takes aim at CVS with a $2 billion purchase at Fortune
12:39PM  CVS Health (CVS) Stock Rising Today After BMO Capital Markets Price Target Hike at TheStreet
11:25AM  Rite Aid PBM Purchase Differentiates It From CVS and Walgreens at 24/7 Wall St.
11:07AM  Rite Aid: The Next CVS? at Barrons.com
10:38AM  Cramer: Rite Aid Continues to Impress, Shares Will Hit New Highs at TheStreet
09:24AM  Cramer's Mad Dash: RAD's growth story CNBC
08:39AM  Rite Aid To Buy Pharmacy Benefits Manager EnvisionRX at Investor's Business Daily
06:10AM  Buy CVS Health After 4Q Revenue, Earnings Beat Expectations at TheStreet
01:39AM  [$$] Corporate Watch: News Digest at The Wall Street Journal
Feb-10-15 06:00PM  Making Money With Charles Payne: 02/10/15 at Fox Business
04:58PM  WSJ Market Wrap: Feb. 10, 2015 at MarketWatch
04:41PM  CVS Health: Smoke-Less Sales Drag Less Than Expected at Investor's Business Daily
04:40PM  U.S. stocks rally into close on Greece deal hopes at MarketWatch
04:37PM  Stocks Gain On Greek Hopes, Coke's Quarter; Oil Falls at Barrons.com
04:13PM  Stocks Rally as Optimism Over Greek Debt Agreement Builds at TheStreet
03:02PM  CVS Health (CVS) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
02:55PM  CVS: No Smoke, On Fire at Barrons.com
11:37AM  Greeks soften tone as Germans stand firm at CNBC
11:35AM  CVS Health Boosted by Medicaid Gains at The Wall Street Journal
11:27AM  Cramer: CVS a Buy; Strong Dollar Not Hurting Travel to U.S. at TheStreet
11:10AM  CVS Health Earnings in Line, Revenues Beat Estimates in Q4 - Analyst Blog Zacks
10:19AM  Analyst: CVS's elimination of tobacco offered 'wide-sprea... CNBC
09:52AM  Cramer's Stop Trading: CVS CNBC
09:38AM  Greek Drama Takes Intermission - Ahead of Wall Street Zacks
09:36AM  CVS Health (CVS) Stock Gains Today Following Earnings Release at TheStreet
09:30AM  Take Two Interactive, BP, Taiwan Semiconductor, CVS Health and HealthSouth highlighted as Zacks Bull and Bear of the Day - Press Releases Zacks
09:18AM  Coke pops; Molson Coors profits fall; Qualcomm jumps on China settlement Yahoo Finance
09:03AM  Oils limbo dance and the upside of Greece adopting the U.S. dollar at MarketWatch
08:57AM  Morning Movers: Coca-Cola, CVS Jump on Earnings Beat; Urban Outfitters Flies on Sales at Barrons.com
08:55AM  Stock Futures Stretch Higher; Starwood, Coca-Cola, CVS Climb at Investor's Business Daily
08:28AM  CVS Health (CVS) Q4 Earnings in Line, Beats Revenue Estimates - Tale of the Tape Zacks
08:08AM  CVS Health Kicks Smoking Habit And Still Has Record Sales at Forbes
08:01AM  Updates, advisories and surprises at MarketWatch
07:51AM  Early movers: KO, CVS, HOT, HD, GPS & more at CNBC
07:16AM  CVS Health revenue rises nearly 13 pct Reuters
07:08AM  Wall Street rally mode?; Coca-Cola earnings; robots taking jobs Yahoo Finance
07:07AM  Q4 2014 CVS Health Corp Earnings Release - Before Market Open CCBN
07:04AM  CVS HEALTH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:00AM  CVS Health Reports Strong Profit Growth For Full Year 2014; Fourth Quarter Adjusted EPS At High End Of Company's Expectations PR Newswire
06:41AM  Will early data back up the blowout jobs report? at CNBC
05:25AM  Premarkets: 5 things to know before the open at CNNMoney.com
Feb-09-15 06:44PM  Here's how a janitor amassed an $8m fortune at CNBC
04:16PM  CVS Health Corp. To Post First Tobacco-Free Quarter On Tuesday Benzinga
03:28PM  What to Watch in the Day Ahead - Tuesday, Feb. 10 Reuters
01:50PM  A Choppy Start to a New Year - Analyst Blog Zacks
12:45PM  What to Expect When CVS Health (CVS) Reports Earnings Results Tuesday at TheStreet
11:00AM  Will CVS Health's (CVS) Earnings Surprise this Season? - Analyst Blog Zacks
10:17AM  CVS Health Has Momentum, While Walgreens Is Playing Catch-up at TheStreet
10:11AM  Proven: People Don't Take Medicine They Can't Afford! at Forbes
08:00AM  CVS Health Showing Strong Vital Signs Ahead of Fourth-Quarter Earnings at TheStreet
Feb-07-15 08:02AM  Will CVS Report Healthy Growth In Q4 EPS And Sales? at Investor's Business Daily
Feb-06-15 07:00PM  Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan at TheStreet
07:00PM  Cramer: It's time to buy these stocks CNBC
06:09PM  Cramer game plan: Next week's hot stocks to watch at CNBC
06:00PM  Cramer's earnings plan: MAS, CVS & more CNBC
01:00AM  Football legend Roger Staubach's company leading Walgreens expansion in Hawaii at American City Business Journals
Feb-05-15 06:18PM  Rite Aid Launches 24 RediClinics within Pharmacies - Analyst Blog Zacks
12:45PM  CVS Health Announces Data from Smoking Cessation Outreach on One-Year Anniversary of Decision to Stop Tobacco Sales PR Newswire
08:30AM  CVS Health Foundation Commits $5 Million to Campaign for Tobacco-Free Kids PR Newswire
Feb-04-15 12:13PM  Pricing wars heat up over hepatitis C drugs at CNBC
09:07AM  CVS/pharmacy Offers Classic Gift Options and Sweet Savings for Valentine's Day PR Newswire
Feb-03-15 04:45PM  Amazon's Payments Business Getting Traction at Investor's Business Daily
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit management services, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private organizations, other sponsors of health benefit plans, and individuals under the CVS/caremark Pharmacy Services, Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, Coram CVS/specialty, NovoLogix, and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. As of December 31, 2014, it operated 7,822 retail drugstores, 860 health care clinics, 17 onsite pharmacy stores, 27 retail specialty pharmacy stores, 11 specialty mail order pharmacies, 4 mail service dispensing pharmacies, and 86 branches, as well as 6 centers of excellence for infusion and enteral services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts Jonathan CEVP & President, CVS/caremarkJan 07Option Exercise41.1786,4873,560,670117,955Jan 08 04:12 PM
Roberts Jonathan CEVP & President, CVS/caremarkJan 07Sale95.3186,4878,243,07631,468Jan 08 04:12 PM
MERLO LARRY JPresident and CEOJan 05Option Exercise41.17144,1445,934,408220,273Jan 06 05:33 PM
MERLO LARRY JPresident and CEOJan 05Sale94.30144,14413,592,77976,129Jan 06 05:33 PM
Lofberg Per GHEVPJan 02Option Exercise45.07347,34315,654,749370,762Jan 05 04:52 PM
Brennan Troyen AEVP, Chief Medical OfficerJan 02Option Exercise34.9650,2401,756,39091,487Jan 05 04:58 PM
Lofberg Per GHEVPJan 02Sale95.28347,34333,096,43923,419Jan 05 04:52 PM
Sussman AndrewSVP & Pres, CVS/minuteclinicJan 02Sale95.674,220403,7132,817Jan 05 05:00 PM
Brennan Troyen AEVP, Chief Medical OfficerJan 02Sale95.7150,2404,808,51641,247Jan 05 04:58 PM
Foulkes HelenaEVP, President-CVS/pharmacyNov 07Option Exercise39.3246,3251,821,35838,040Nov 10 05:11 PM
Foulkes HelenaEVP, President-CVS/pharmacyNov 07Sale88.0646,3254,079,58418,076Nov 10 05:11 PM
Bisaccia LisaSVP, Chief HR OfficerOct 27Option Exercise40.6527,5861,121,39538,730Oct 28 04:07 PM
Bisaccia LisaSVP, Chief HR OfficerOct 27Sale85.0033,5072,848,09517,281Oct 28 04:07 PM
Sussman AndrewSVP & President, MinuteClinicSep 02Option Exercise36.969,020333,37916,057Sep 03 04:43 PM
Sussman AndrewSVP & President, MinuteClinicSep 02Sale79.459,020716,6397,037Sep 03 04:43 PM
Joyner J. DavidEVP, Sales & Account ServicesAug 06Option Exercise31.12123,5163,843,942123,018Aug 07 04:14 PM
Joyner J. DavidEVP, Sales & Account ServicesAug 06Sale76.10123,5169,399,56845,399Aug 07 04:14 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 21Option Exercise30.1622,107666,74739,870Jul 22 04:22 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 21Sale76.7722,1071,697,15417,763Jul 22 04:22 PM
Denton David MEVP, CFOJul 01Option Exercise32.7774,9892,457,611161,873Jul 03 04:13 PM
Denton David MEVP, CFOJul 01Sale75.8874,9895,690,16586,884Jul 03 04:13 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerApr 02Option Exercise43.9517,108751,96524,391Apr 03 04:41 PM
Sussman AndrewSVP & President, MinuteClinicApr 02Option Exercise47.9819,210921,61820,138Apr 03 04:44 PM
Sussman AndrewSVP & President, MinuteClinicApr 02Sale74.0219,2101,422,0136,829Apr 03 04:44 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerApr 02Sale74.5117,1081,274,71717,737Apr 03 04:41 PM
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.08%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month3.53%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter5.44%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y14.32%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year23.30%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range54.79 - 72.74 Perf YTD5.64%
Dividend0.96 P/FCF- EPS past 5Y- ROI- 52W High-0.69% Beta-
Dividend %1.33% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low31.86% ATR0.80
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)60.94 Volatility0.72% 1.13%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.64 Prev Close72.59
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume10.50M Price72.24
Recom- SMA202.08% SMA503.14% SMA20011.69% Volume6,724,409 Change-0.48%
Feb-27-15 04:02PM  The week ahead: Buffett on Squawk Box Monday CNBC
03:05PM  Increased Mergers and Acquistions Help, But Headwinds Persist Market Realist
11:06AM  Rationale of the SalixValeant merger Market Realist
08:04AM  Why should you invest in healthcare ETFs? Market Realist
07:18AM  Why antibiotics need innovation: Ezekiel Emanuel CNBC
Feb-26-15 05:06PM  Basics of the SalixValeant merger transaction Market Realist
03:55PM  Health Care Stocks Flexing Their Muscle at Forbes
01:02PM  The SalixValeant merger will follow a cash tender timeline Market Realist
10:01AM  Nasdaq pursues 5K CNBC
Feb-25-15 01:07PM  Global market check CNBC
10:17AM  Humanas income rises 21% year-over-year in 4th-quarter 2014 Market Realist
10:02AM  Ned Davis Research Looks Beyond the Plain-Vanilla ETF in Health Care at Barrons.com
Feb-24-15 04:49PM  Don't kid yourself: stocks are just as overvalued today as they were in 2000 Yahoo Finance Contributors
01:46PM  Top Ranked Healthcare Service ETF in Focus: IHF - ETF News And Commentary Zacks
01:00PM  Yes, Healthcare ETFs can Keep Rising ETF Trends
12:56PM  Will there ever be another correction? at MarketWatch
12:05PM  Humanas valuations tied to its reliance on Medicare Market Realist
10:14AM  And Stocks take the lead... Yahoo Finance Contributors
10:05AM  Humanas financial risk managed by capital requirements Market Realist
10:05AM  Humana spends most on hospital benefits Market Realist
09:05AM  Marketing, brand, and big pharmas real consumer targets Market Realist
09:05AM  How Humana sells health plans on public and private exchanges Market Realist
08:05AM  Most Humana stakeholders are mutual funds or advisers Market Realist
Feb-23-15 08:05PM  Humana and the specialty insurance business Market Realist
07:05PM  Health insurer Humanas major business risks Market Realist
04:03PM  Healthcare Breaks Out: More Upside Is Ahead at Barrons.com
10:23AM  Peterson's top sectors CNBC
09:01AM  Hedge Fund Stress, Support & Risk Yahoo Finance Contributors
08:01AM  The Ron Popeil Trade Yahoo Finance Contributors
Feb-20-15 09:51PM  The Week Ahead: Run with the Bulls in March? at Forbes
04:42PM  Friday's Market Recap Yahoo Finance Contributors
12:05PM  Increased Life Expectancy Means A Longer Investment Horizon Market Realist
10:53AM  Heres Why I Like Healthcare Yahoo Finance Contributors
Feb-19-15 03:54PM  Stick With Health Care and Consumer Discretionary, Avoid Energy at TheStreet
02:05PM  Humana set to benefit from state-based contracts Market Realist
Feb-18-15 04:39PM  Wednesday's Market Recap Yahoo Finance Contributors
04:06PM  Humana rumored to be making a move with pharmacy business Market Realist
12:06PM  Humana networks with Wal-Mart mean lower member premiums Market Realist
10:06AM  Municipal Bonds Help You Care For Communities Market Realist
Feb-17-15 07:06PM  Humana to benefit from growing Medicare eligible population Market Realist
05:20PM  The Riskalyze Report: Advisors get out of short duration bonds Yahoo Finance Contributors
02:06PM  Humanas integrated care delivery strategy Market Realist
11:38AM  Buy More Stocks in a Top Sector at Forbes
10:06AM  Humanas key health insurance markets Market Realist
09:38AM  Pisani's market open: Transocean cuts dividend CNBC
09:01AM  Hedge Fund Stress, Support & Risk Yahoo Finance Contributors
08:02AM  Who Won and Who Lost This Earnings Season? Yahoo Finance Contributors
05:15AM  A New Exercise in Industry Rotation Yahoo Finance Contributors
Feb-16-15 04:06PM  Humanas Retail Insurance business segment is biggest earner Market Realist
02:05PM  Affordable Care Act benefits health insurance company valuations Market Realist
11:28AM  Humana: Unraveling the history of a health insurance giant Market Realist
10:05AM  Acquisitions and divestitures shape private health insurance Market Realist
Feb-13-15 04:05PM  Who wields negotiation power in the healthcare industry? Market Realist
02:13PM  State Street Slashes Fees on 41 ETFs - ETF News And Commentary Zacks
01:05PM  Understanding health insurance companies major operating expenses Market Realist
12:16PM  Deal stocks rise, emboldening bankers, bull run at CNBC
09:35AM  Pisani's market open: S&P targets all-time high CNBC
07:51AM  Measles outbreak in techland CNBC
Feb-12-15 06:05PM  The health insurance industrys major sources of revenue: A guide Market Realist
02:05PM  Health insurance monopolies: What you need to know Market Realist
11:05AM  Underwriting cycle: What health insurance investors need to know Market Realist
Feb-11-15 04:42PM  Wednesday Market Recap Yahoo Finance Contributors
04:05PM  Medical cost trend means rising premiums for health insurance Market Realist
12:06PM  Why the Affordable Care Act hurts the managed care industry Market Realist
Feb-10-15 06:05PM  Why Medicaid managed care offers a lucrative revenue opportunity Market Realist
05:13PM  SPDR® ETF Family Announces Impact of Receiving Settlement Payment Business Wire
02:05PM  Why Medicare Advantage drives health insurance stocks Market Realist
01:07PM  Consumers benefit in this environment: Pro CNBC
01:06PM  Private insurance companies should benefit from demographic trends Market Realist
11:31AM  Healthcare Is Ready For Another Leg Higher Yahoo Finance Contributors
07:03AM  Earnings scorecard: Bulk beats estimates CNBC
Feb-09-15 04:05PM  Shift to self-insurance plans affects health insurance stocks Market Realist
03:06PM  Why jobs are so essential to health insurance industry profits Market Realist
09:01AM  Hedge Fund Stress, Support & Risk Yahoo Finance Contributors
07:53AM  Ice bucket's $115 million challenge CNBC
07:32AM  Should government mandate vaccines? CNBC
Feb-06-15 06:06PM  Health insurance varies by geography, affecting XLV stocks Market Realist
02:05PM  The rise in insurance demand can benefit managed care stocks Market Realist
12:05PM  Must-know distribution channels for commercial health plans Market Realist
10:00AM  Pfizer Set to Acquire Hospira: Healthcare ETFs in Focus - ETF News And Commentary Zacks
08:20AM  A CURE for the Ordinary Health Care ETF ETF Trends
08:02AM  Dow's top leaders and laggards CNBC
Feb-05-15 04:06PM  2 key business models of the health insurance industry Market Realist
12:05PM  Making sense of health insurance companies payment options Market Realist
08:03AM  US lagging in measles immunizations CNBC
Feb-04-15 06:06PM  Your must-read guide to health insurance managed care plans Market Realist
02:06PM  Making sense of health insurance types: An investors guide Market Realist
10:05AM  The health insurance industrys key players and origins Market Realist
09:38AM  Pisani's market open: 4 market stressors CNBC
07:18AM  Picking apart vaccine safety net: Expert CNBC
Feb-03-15 10:12AM  Time to take a step back. Yahoo Finance Contributors
07:45AM  Measles outbreak triggers vaccine debate CNBC
Feb-02-15 01:35PM  Volatility will continue but bias will improve: Pro CNBC
09:01AM  Top Hedge Fund Positions Exceed S&P 500 Decline Yahoo Finance Contributors
08:45AM  Technical Market Outlook: Trend, Breadth, Momentum, China, & Financial Stress Yahoo Finance Contributors
08:44AM  January Redux Yahoo Finance Contributors
Jan-30-15 03:51PM  Cashin: Sellers close out January CNBC
01:06PM  Why Traditional Low-Beta Sectors Provide Relative Safety Market Realist
Jan-29-15 04:54PM  Thursday's Market Recap Yahoo Finance Contributors
03:51PM  Pro likes healthcare, consumer staples CNBC
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG [NYSE]
ConAgra Foods, Inc.
IndexS&P 500 P/E291.50 EPS (ttm)0.12 Insider Own0.10% Shs Outstand431.00M Perf Week1.33%
Market Cap15.08B Forward P/E15.18 EPS next Y2.30 Insider Trans-68.43% Shs Float428.96M Perf Month-4.24%
Income55.10M PEG35.12 EPS next Q0.54 Inst Own74.60% Short Float1.29% Perf Quarter-0.82%
Sales16.68B P/S0.90 EPS this Y-62.20% Inst Trans4.67% Short Ratio1.91 Perf Half Y10.42%
Book/sh13.08 P/B2.67 EPS next Y6.72% ROA2.00% Target Price35.00 Perf Year27.57%
Cash/sh0.28 P/C123.68 EPS next 5Y8.30% ROE7.20% 52W Range27.26 - 37.21 Perf YTD-2.91%
Dividend1.00 P/FCF30.09 EPS past 5Y-12.30% ROI4.20% 52W High-5.99% Beta0.42
Dividend %2.86% Quick Ratio0.50 Sales past 5Y7.50% Gross Margin20.40% 52W Low28.34% ATR0.59
Employees32800 Current Ratio1.20 Sales Q/Q-1.70% Oper. Margin4.20% RSI (14)45.17 Volatility1.03% 1.63%
OptionableYes Debt/Eq1.52 EPS Q/Q-89.60% Profit Margin2.40% Rel Volume0.98 Prev Close34.67
ShortableYes LT Debt/Eq1.38 EarningsMar 26 BMO Payout105.30% Avg Volume2.90M Price34.98
Recom3.00 SMA20-1.15% SMA50-2.46% SMA2005.70% Volume2,829,310 Change0.89%
Sep-19-14Reiterated RBC Capital Mkts Sector Perform $31 → $35
Feb-12-14Reiterated Deutsche Bank Hold $35 → $31
Nov-26-13Initiated RBC Capital Mkts Sector Perform $33
Sep-11-13Reiterated Barclays Overweight $40 → $38
Apr-03-13Reiterated Deutsche Bank Hold $35 → $40
Feb-20-13Reiterated Deutsche Bank Hold $31 → $32
Jan-24-13Reiterated UBS Buy $38 → $36
Nov-28-12Reiterated Deutsche Bank Hold $29 → $31
Sep-21-12Upgrade UBS Neutral → Buy $27 → $31
Jul-25-12Initiated KeyBanc Capital Mkts Buy $30
May-05-11Reiterated Deutsche Bank Hold $23 → $28
Sep-22-10Reiterated Barclays Capital Equal Weight $27 → $25
Sep-17-10Reiterated Deutsche Bank Hold $26 → $25
Mar-22-10Reiterated Credit Suisse Neutral $24 → $27
Sep-23-09Reiterated Credit Suisse Neutral $21 → $24
Jun-23-09Upgrade UBS Neutral → Buy
Jun-15-09Downgrade Citigroup Buy → Hold
Mar-27-09Upgrade Bernstein Underperform → Mkt Perform
Mar-25-09Reiterated Credit Suisse Neutral $18 → $16
Dec-18-08Reiterated UBS Neutral $15 → $17
Feb-23-15 06:26PM  ConAgra Foods Inc., Paramount Group Inc, Altera Corporation: Billionaire Ken Griffins Biggest New Bets at Insider Monkey
Feb-13-15 06:25PM  Cramer: These food companies now irrelevant CNBC
06:00PM  Cramer: This stock can sprout more gains CNBC
12:44PM  Food company shares slump as they lower outlooks, miss on earnings at MarketWatch
11:14AM  ConAgra Foods (CAG) Stock Declines Today on Lowered 2015 Earnings Guidance at TheStreet
Feb-12-15 06:43PM  ConAgra Names Hillshire Brands' Connolly CEO at The Wall Street Journal
05:24PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi EDGAR Online
05:23PM  ConAgra names former Hillshire Farms CEO Connolly to top post at MarketWatch
05:13PM  Poultry giant names new CEO, cuts profit forecasts at CNBC
04:54PM  ConAgra names Sean Connolly CEO, cuts 2015 profit forecast Reuters
04:48PM  ConAgra Foods Names Hillshire Brands Sean Connolly as Next CEO at Bloomberg
04:44PM  ConAgra cuts 2015 earnings outlook, names new CEO at MarketWatch
04:30PM  ConAgra Foods Announces Sean Connolly as New CEO Business Wire
04:25PM  ConAgra Foods Revises Fiscal 2015 EPS Outlook; Fiscal 2015 Comparable EPS $2.13-$2.18; Fiscal 2015 Debt Reduction Goal Reaffirmed; Commitment to Strong Dividend Reaffirmed Business Wire
08:38AM  Jerky: An Industry That's Anything But Dried Up at Forbes
Feb-03-15 12:39PM  Survey Finds Millennials Need Help Cooking a Romantic Valentine's Day Meal PR Newswire
Jan-27-15 06:34PM  Post Holdings to Buy MOM Brands, Boost Cereal Category - Analyst Blog Zacks
Jan-26-15 12:33PM  Mondelz restructuring aimed at lowering operating costs Market Realist
Jan-20-15 01:00PM  ConAgra Foods Announces Community Effort Exceeded Goal of Raising 1.3 Million Meals to Help Shine the Light on Hunger Business Wire
Jan-15-15 05:11PM  ConAgra event cancellation sparks rumors, options activity Reuters
Jan-12-15 04:46PM  ConAgra Execs Sell $17M in Stock Near Record High at Barrons.com
12:42PM  Midday movers: SanDisk, Chevron, Google & more at CNBC
10:09AM  ConAgra Foods (CAG) Stock Lower Today After Citigroup Downgrade at TheStreet
Jan-03-15 01:04PM  CONAGRA FOODS INC /DE/ Financials EDGAR Online Financials
Jan-02-15 08:05AM  Five US tech hubs you probably didn't know about at CNBC
Dec-31-14 03:08AM  Puts show comfort in ConAgra optionMONSTER
Dec-29-14 02:24PM  CONAGRA FOODS INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
Dec-21-14 06:00PM  Why the next world war will be fought over food at Fortune
08:30AM  5 Trade Ideas for Monday: Domino's, Conagra, Schlumberger, AmerisourceBergen & Weyerhaeuser Yahoo Finance Blogs
Dec-18-14 05:45PM  Stock Pops & Drops: MGM, RAD, NAV & CAG CNBC
03:08PM  Conagra Foods (CAG) Earnings Report: Q2 2014 Conference Call Transcript at TheStreet
01:13PM  Kraft Hits Record High After John Cahill Named CEO at Investor's Business Daily
12:43PM  Midday movers: Microsoft, Rite Aid, Pfizer & more at CNBC
12:40PM  ConAgra's Earnings Miss On Private Label Slide at Investor's Business Daily
09:55AM  ConAgra's Profit Plunges on Private-Label Write-Down at The Wall Street Journal
09:46AM  ConAgra Foods (CAG) Stock Declines Today on Mixed Second Quarter Earnings Results at TheStreet
09:30AM  ConAgra Foods Inc Earnings Call scheduled for 9:30 am ET today CCBN
09:16AM  Sony pulls plug on 'The Interview'; Oracle finally gets a lift from the cloud; Rite Aid soars Hot Stock Minute
08:58AM  ConAgras bet on private label continues to sour at Fortune
08:31AM  #PreMarket Primer: Thursday, December 18: Hackers' Threat Causes Sony To Cancel Movie Release Benzinga
07:52AM  Fed-fueled rally continues; Fallout from threat to Sony not over; U.S. companies eye Cuba Hot Stock Minute
07:39AM  ConAgra meets 2Q profit forecasts AP
07:37AM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Material Impairments, Finan EDGAR Online
07:30AM  ConAgra Foods Second-Quarter Comparable EPS as Planned; Fiscal 2015 EPS Guidance and Debt Reduction Goal Reaffirmed; Consumer and Commercial Fundamentals Improve; Private Brands Declines, Recognizes Impairment Business Wire
07:07AM  Q2 2015 ConAgra Foods Inc Earnings Release - Before Market Open CCBN
Dec-17-14 10:54AM  Can ConAgra's $150 Million Bet on Potatoes Send Shares Higher in 2015? at TheStreet
10:00AM  What to Expect When ConAgra Foods (CAG) Reports Its Earnings Results at TheStreet
Dec-15-14 09:40AM  Will ConAgra Beat Q2 Estimates on Accretive Acquisitions? Zacks
08:56AM  Deutsche Bank Previews ConAgra Foods' Q2 Earnings Benzinga
Dec-12-14 05:59PM  Dividend Stocks: ConAgra Potato Plants Fuel Growth at Investor's Business Daily
09:40AM  ConAgra Hits 52-Week High on Burgeoning Frozen Potato Trade Zacks
Dec-11-14 12:00PM  ConAgra Foods Announces Details of Fiscal 2015 Second-Quarter Earnings Release and Conference Call Business Wire
Dec-10-14 06:09PM  Final Glance: Food companies AP
Dec-09-14 08:30AM  Diamond Foods Beats on Q1 Earnings, Retains FY15 View Zacks
Dec-05-14 12:20PM  ConAgra JV to Invest $150M for Netherlands Plant Extension Zacks
Dec-04-14 09:30AM  ConAgra Foods European Joint Venture to Expand Potato Processing Operations in Netherlands Business Wire
Dec-02-14 11:17AM  ConAgra Foods Announces Dividend Payment Business Wire
Nov-28-14 05:27AM  Louis Dreyfus Commodities Appoints Mayo Schmidt as New CEO at Bloomberg
Nov-26-14 08:49AM  The Zacks Analyst Blog Highlights: Hewlett-Packard, ConAgra Foods, McCormick and Dr Pepper Snapple Group Zacks
Nov-24-14 08:00AM  ConAgra Foods and ConAgra Foods Foundation Not Satisfied with the Results of Their 20-Year Fight Against Child Hunger in America Business Wire
Nov-21-14 05:20PM  Sysco to Reward Shareholders with 3.4% Hike in Dividend Zacks
04:15PM  ConAgra Boosts Chinese Business with Shangdu Plant Zacks
Nov-20-14 01:19PM  Keurig Green Mountain Tops Q4 & FY14 Earnings, Sales Zacks
09:05AM  U.S. Thanksgiving meal costs barely rise as price of turkey slips Reuters
09:00AM  ConAgra Foods Lamb Weston Celebrates Grand Opening of Potato Processing Plant in China Business Wire
Nov-17-14 04:35PM  B&G Foods (BGS) Recalls Ortega and Las Palmas Products Zacks
Nov-11-14 08:30AM  Dean Foods Gains on Narrower than Expected Q3 Loss Zacks
Nov-10-14 02:10PM  ConAgra Hits 52-Week High on Healthy Q1 Earnings Beat Zacks
01:52PM  General Mills Shares Dip 3.6% on 2015 Guidance Cut Zacks
12:12PM  Why Now Is the Best Time for Investors to Bite Into Dean Foods at TheStreet
06:15AM  Treehouse Foods (THS) Crumbles: Stock Falls by 6.2% Zacks
Nov-07-14 08:00AM  Hain Celestial Q1 Earnings Beat Estimates, Outlook Intact Zacks
Nov-04-14 12:04PM  Ardagh Group opens plant in Virginia AP
09:00AM  Supermarket Guru® Predicts Top Food Trends for 2015 PR Newswire
Oct-31-14 02:13PM  Acquisition Strategy Will Benefit ConAgra Foods Gurufocus
Oct-30-14 12:27PM  Source Says Snow Phipps Wins PE-backed Teasdale Foods for About $200 Million TheStreet
Oct-29-14 01:10PM  Hershey Lags Q3 Earnings on High Dairy Costs; Cuts FY View Zacks
Oct-24-14 04:01PM  Sandell Asset Management's Plans for Bob Evans Farms May Include M&A at TheStreet
Oct-22-14 04:42PM  General Mills (GIS) Acquires Annie's to Boost Top Line Zacks
Oct-20-14 09:00AM  New Research Points to Popcorn and Frozen Meals for Cutting Calories Business Wire
Oct-17-14 10:00AM  Thanks to Michelle Obama, healthy school lunch startups get a boost at Fortune
Oct-14-14 01:40PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
12:40PM  Cargill to distribute ConAgra condiments, popcorn in Brazil Reuters
Oct-09-14 01:05PM  Slim Jim and AMC's "The Walking Dead" Bring Fans Show-Inspired "Carnage Asada" Flavor Business Wire
Oct-06-14 03:35PM  Hain Celestial Riding on Organic Wave: Add HAIN to Portfolio Zacks
Oct-05-14 05:01PM  5 Trade Ideas for Monday: American Tower, Conagra, Cigna, Skyworks Solutions and Weyerhaeuser Yahoo Finance Blogs
Oct-04-14 08:25AM  Why Food 2.0 is techs next big start-up craze at MarketWatch
Oct-03-14 10:45AM  5 Stocks That Will See Big Selling on Huge ETF Rebalance at 24/7 Wall St.
Oct-02-14 10:30AM  ConAgra Posts Solid Organic & Inorganic Growth, Runs Risks Zacks
Oct-01-14 12:31PM  Why Investors Should Take a Bite of ConAgras Stock Right Now at TheStreet
Sep-30-14 09:00AM  Skinnygirl and Orville Redenbacher's® Partner for Debut of New Skinnygirl Popcorn Business Wire
03:00AM  Annual Report for ConAgra Foods, Inc. Company Spotlight
Sep-29-14 11:59AM  CONAGRA FOODS INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
06:43AM  Diamond Foods (DMND) Jumps: Stock Moves 7.3% Higher Zacks
Sep-25-14 09:00AM  Wolf Brand Chili Tours the State to Find the Bold Spirit of Texas Business Wire
Sep-23-14 11:04AM  ADDING MULTIMEDIA Marie Callenders Launches Partnership with USO to Bring Comforts from Home to Servicemen & Women around the Globe Business Wire
Sep-22-14 05:35PM  ConAgra Recovers With Earnings Surprise at Investor's Business Daily
06:01AM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote EDGAR Online
Sep-19-14 09:23AM  Company News for September 19, 2014 Zacks
08:30AM  ConAgra Foods Announces Dividend Payment Business Wire
ConAgra Foods, Inc. operates as a food company primarily in North America. The company operates through three segments: Consumer Foods, Commercial Foods, and Private Brands. The Consumer Foods segment provides branded food products in various categories, such as meals, entrees, condiments, sides, snacks, and desserts to various retail channels, such as grocery and convenience stores across frozen, refrigerated, and shelf-stable temperature classes. This segment's principal brands include Alexia, ACT II, Banquet, Blue Bonnet, Chef Boyardee, DAVID, Egg Beaters, Healthy Choice, Hebrew National, Hunt's, Marie Callender's, Odom's Tennessee Pride, Orville Redenbacher's, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp's, and Wesson. The Commercial Foods segment offers food and ingredients primarily to commercial, foodservice, food manufacturing, and industrial customers. It provides frozen and sweet potato items, vegetable products, and spice and frozen bakery goods under the Lamb Weston, and Spicetec Flavors & Seasonings brand names. The Private Brands segment offers private branded and customized food items in various retail channels, including grocery and convenience stores. Its products consist of hot and ready-to-eat cereals; condiments; bars and coordinated categories; pastas; and retail bakery goods. ConAgra Foods, Inc. was founded in 1919 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wise Robert GSVP, Corporate ControllerJan 17Option Exercise0.005,000015,617Jan 20 04:41 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 06Option Exercise24.7424,800613,55269,280Jan 07 04:33 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 06Sale35.2224,800873,45144,480Jan 07 04:33 PM
McGough Thomas MPresident, Consumer FoodsJan 05Option Exercise23.9011,236268,54060,388Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 05Option Exercise25.32190,0004,810,580253,060Jan 06 05:26 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryJan 05Option Exercise23.9315,000358,950115,943Jan 07 04:32 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 05Option Exercise24.7411,200277,08855,680Jan 07 04:33 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryJan 05Sale35.6015,000534,024100,943Jan 07 04:32 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 05Sale35.6111,200398,82944,480Jan 07 04:33 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 05Sale35.66190,0006,775,30563,060Jan 06 05:26 PM
McGough Thomas MPresident, Consumer FoodsJan 05Sale35.948,779315,50051,609Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 02Option Exercise22.90202,0004,626,300265,060Jan 06 05:26 PM
McGough Thomas MPresident, Consumer FoodsJan 02Option Exercise19.5911,264220,71057,052Jan 06 05:21 PM
McGough Thomas MPresident, Consumer FoodsJan 02Sale36.157,900285,54849,152Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 02Sale36.03202,0007,278,34363,060Jan 06 05:26 PM
Wise Robert GSVP, Corporate ControllerDec 23Option Exercise23.906,600157,74017,217Dec 23 04:28 PM
Wise Robert GSVP, Corporate ControllerDec 23Sale36.906,600243,54510,617Dec 23 04:28 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyDec 22Option Exercise24.80198,0004,911,300303,795Dec 23 04:21 PM
Gehring JohnEVP and CFODec 22Option Exercise21.10160,0003,375,200207,427Dec 23 04:25 PM
Gehring JohnEVP and CFODec 22Sale36.82160,0005,891,52047,427Dec 23 04:25 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyDec 22Sale36.58176,0006,438,925127,795Dec 23 04:21 PM
McGough Thomas MPresident, Consumer FoodsNov 28Option Exercise19.055,00095,25049,197Dec 02 04:28 PM
McGough Thomas MPresident, Consumer FoodsNov 28Sale36.003,409122,72445,788Dec 02 04:28 PM
McGough Thomas MPresident, Consumer FoodsNov 18Option Exercise19.055,00095,25047,657Nov 20 04:50 PM
McGough Thomas MPresident, Consumer FoodsNov 18Sale35.003,460121,10044,197Nov 20 04:50 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerSep 24Option Exercise21.26120,0002,551,200168,562Sep 26 04:29 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerSep 24Sale33.44120,0004,013,24448,562Sep 26 04:29 PM
McGough Thomas MPresident, Consumer FoodsSep 23Option Exercise21.266,900146,69447,898Sep 24 05:20 PM
McGough Thomas MPresident, Consumer FoodsSep 23Sale33.135,241173,63442,657Sep 24 05:20 PM
McGough Thomas MPresident, Consumer FoodsSep 22Option Exercise21.263,10065,90640,998Sep 24 05:20 PM
STINSON KENNETH EDirectorJul 14Option Exercise25.779,000231,93095,465Jul 16 05:48 PM
Theophilus Nicole BEVP, Chief HR OfficerJul 14Option Exercise24.7428,000692,72061,918Jul 16 05:49 PM
Theophilus Nicole BEVP, Chief HR OfficerJul 14Sale30.6328,000857,66533,918Jul 16 05:49 PM
STINSON KENNETH EDirectorJul 14Sale30.587,591232,13487,874Jul 16 05:48 PM
Wise Robert GSVP, Corporate ControllerJul 11Option Exercise0.005,000012,229Jul 15 04:32 PM
JURGENSEN WILLIAM GDirectorJul 09Option Exercise25.779,000231,93098,907Jul 11 04:26 PM
JURGENSEN WILLIAM GDirectorJul 09Sale30.647,581232,28291,326Jul 11 04:26 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise25.779,000231,93065,787Jul 09 05:07 PM
BUTLER STEPHEN GDirectorJul 07Sale30.999,000278,91056,787Jul 09 05:07 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyJul 03Option Exercise26.1542,0001,098,300133,705Jul 08 05:10 PM
McGough Thomas MPresident, Consumer FoodsJul 03Option Exercise21.2610,000212,60032,851Jul 08 05:13 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyJul 03Sale31.0242,0001,302,84891,705Jul 08 05:10 PM
McGough Thomas MPresident, Consumer FoodsJul 03Sale31.073,937122,32328,914Jul 08 05:13 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerJul 02Sale30.3680024,2880Jul 07 04:36 PM
BAY MOGENS CDirectorJul 01Option Exercise25.779,000231,93075,281Jul 03 05:02 PM
BAY MOGENS CDirectorJul 01Sale29.677,827232,22267,454Jul 03 05:02 PM
RODKIN GARY MPresident and CEOJun 30Option Exercise26.8050,0001,340,000689,765Jul 01 07:05 PM
RODKIN GARY MPresident and CEOJun 30Sale29.3550,0001,467,360639,765Jul 01 07:05 PM
RODKIN GARY MPresident and CEOJun 23Option Exercise26.8050,0001,340,000689,765Jun 24 04:19 PM
RODKIN GARY MPresident and CEOJun 23Sale28.8450,0001,441,980639,765Jun 24 04:19 PM
RODKIN GARY MPresident and CEOJun 16Option Exercise26.8050,0001,340,000689,765Jun 17 04:40 PM
RODKIN GARY MPresident and CEOJun 16Sale32.4450,0001,622,000639,765Jun 17 04:40 PM
RODKIN GARY MPresident and CEOJun 09Option Exercise26.8050,0001,340,000689,765Jun 10 08:28 PM
RODKIN GARY MPresident and CEOJun 09Sale32.6550,0001,632,350639,765Jun 10 08:28 PM
RODKIN GARY MPresident and CEOJun 02Option Exercise26.8050,0001,340,000689,765Jun 03 04:36 PM
RODKIN GARY MPresident and CEOJun 02Sale32.1950,0001,609,295639,765Jun 03 04:36 PM
RODKIN GARY MPresident and CEOMay 27Option Exercise26.8050,0001,340,000689,765May 29 06:10 PM
RODKIN GARY MPresident and CEOMay 27Sale31.5750,0001,578,365639,765May 29 06:10 PM
RODKIN GARY MPresident and CEOMay 19Option Exercise26.8050,0001,340,000689,765May 21 04:25 PM
RODKIN GARY MPresident and CEOMay 19Sale31.2750,0001,563,550639,765May 21 04:25 PM
RODKIN GARY MPresident and CEOMay 12Option Exercise26.8050,0001,340,000689,765May 14 05:15 PM
RODKIN GARY MPresident and CEOMay 12Sale30.8350,0001,541,340639,765May 14 05:15 PM
RODKIN GARY MPresident and CEOMay 05Option Exercise26.8050,0001,340,000689,765May 07 04:30 PM
RODKIN GARY MPresident and CEOMay 05Sale30.1750,0001,508,720639,765May 07 04:30 PM
RODKIN GARY MPresident and CEOApr 28Option Exercise26.8050,0001,340,000689,765Apr 30 04:19 PM
RODKIN GARY MPresident and CEOApr 28Sale30.8650,0001,542,760639,765Apr 30 04:19 PM
Theophilus Nicole BEVP, Chief HR OfficerApr 01Option Exercise24.7420,000494,80053,918Apr 03 05:01 PM
Theophilus Nicole BEVP, Chief HR OfficerApr 01Sale30.7620,000615,23233,918Apr 03 05:01 PM
Theophilus Nicole BEVP, Chief HR OfficerMar 24Option Exercise23.9318,000430,74051,918Mar 26 04:21 PM
GREGOR JOIE ADirectorMar 24Buy30.263,30099,84733,017Mar 26 04:19 PM
Theophilus Nicole BEVP, Chief HR OfficerMar 24Sale30.1118,000541,98033,918Mar 26 04:21 PM
GILD [NASD]
Gilead Sciences Inc.
IndexS&P 500 P/E13.82 EPS (ttm)7.49 Insider Own0.40% Shs Outstand1.50B Perf Week0.90%
Market Cap155.19B Forward P/E9.95 EPS next Y10.41 Insider Trans-23.90% Shs Float1.49B Perf Month1.05%
Income12.10B PEG0.55 EPS next Q2.26 Inst Own85.20% Short Float3.56% Perf Quarter2.39%
Sales24.89B P/S6.24 EPS this Y306.10% Inst Trans-3.25% Short Ratio3.19 Perf Half Y-3.61%
Book/sh10.51 P/B9.85 EPS next Y9.00% ROA58.60% Target Price118.96 Perf Year23.77%
Cash/sh7.82 P/C13.23 EPS next 5Y25.20% ROE122.20% 52W Range63.50 - 116.83 Perf YTD9.83%
Dividend- P/FCF- EPS past 5Y39.10% ROI78.70% 52W High-11.38% Beta0.71
Dividend %- Quick Ratio2.90 Sales past 5Y28.80% Gross Margin84.80% 52W Low63.04% ATR2.36
Employees6100 Current Ratio3.20 Sales Q/Q134.40% Oper. Margin61.80% RSI (14)54.03 Volatility1.50% 2.22%
OptionableYes Debt/Eq0.00 EPS Q/Q373.90% Profit Margin72.30% Rel Volume0.48 Prev Close104.19
ShortableYes LT Debt/Eq0.00 EarningsFeb 03 AMC Payout0.00% Avg Volume16.62M Price103.53
Recom1.80 SMA201.15% SMA502.65% SMA2006.08% Volume7,914,158 Change-0.63%
Feb-04-15Reiterated RBC Capital Mkts Outperform $125 → $118
Dec-23-14Reiterated Deutsche Bank Buy $142 → $125
Dec-09-14Reiterated Argus Buy $110 → $130
Oct-29-14Reiterated RBC Capital Mkts Outperform $115 → $125
Oct-13-14Reiterated FBR Capital Outperform $125 → $130
Sep-25-14Reiterated Needham Buy $95 → $120
Aug-22-14Reiterated RBC Capital Mkts Outperform $102 → $115
Aug-15-14Initiated FBR Capital Outperform $125
Aug-11-14Reiterated Argus Buy $90 → $110
Jul-28-14Reiterated Maxim Group Buy $112 → $127
Jul-24-14Reiterated RBC Capital Mkts Outperform $96 → $102
Apr-28-14Reiterated Maxim Group Buy $101 → $112
Feb-21-14Reiterated Barclays Overweight $90 → $95
Feb-10-14Reiterated Argus Buy $84 → $90
Feb-05-14Reiterated RBC Capital Mkts Outperform $90 → $96
Feb-05-14Reiterated Needham Buy $85 → $95
Feb-05-14Reiterated Maxim Group Buy $98 → $101
Feb-04-14Upgrade Robert W. Baird Neutral → Outperform $65 → $103
Jan-28-14Reiterated Deutsche Bank Buy $95 → $132
Jan-06-14Reiterated UBS Buy $80 → $102
Feb-27-15 12:58PM  Gilead Sciences: 'HIV Succession Plan Coming Into Focus' at Barrons.com
12:50PM  ImmunoVaccine Up 24% On Deal With Gilead Sciences Benzinga
Feb-26-15 07:05PM  Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF) Business Wire
06:51PM  Bristol-Myers: Drug combo cured hepatitis C in 97% with HIV AP
03:45PM  Gilead Avoids Billions in U.S. Tax on Its $1,000-a-Pill Drug Bloomberg
03:19PM  Gilead dodges billions in taxes as money rolls in from hepatitis C drugs at San Jose Mercury News
03:14PM  Gilead Announces SVR12 Rates From Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected With HIV Business Wire
03:05PM  Omega Advisors opens a new position in Gilead Sciences Market Realist
12:51PM  Value hunting in the Nasdaq CNBC
11:10AM  Biotech Making A Comeback - Here Is One Stock to Watch Company Spotlight
11:01AM  Gilead Sciences: Despite Dividend, Still Room For Growth at Barrons.com
09:25AM  Short Sellers Increase Bets Against Biotech as Shares Continue to Rise at 24/7 Wall St.
Feb-25-15 04:11PM  GILEAD SCIENCES INC Files SEC form 10-K, Annual Report EDGAR Online
03:27PM  Gilead Announces Preclinical Data for an Investigational TLR7 Agonist in SIV-Infected, Virally Suppressed Monkeys Business Wire
10:38AM  Gilead & AbbVie: It Doesn't Matter Which Drug is Better, Just Who Will Pay at Barrons.com
09:56AM  13F Filings Takeaway: Own A Dirty Dozen at Forbes
Feb-24-15 05:00PM  Gilead Sciences to Present at the RBC Capital Markets 2015 Healthcare Conference on Wednesday, February 25 Business Wire
03:39PM  Allergan, Inc. (AGN), HCA Holdings Inc (HCA), Gilead Sciences, Inc. (GILD) Among Healthcare Stocks That Billionaires Love at Insider Monkey
03:15PM  Failure of Anti-HIV Vaginal Gel Shows Difficulty of Prevention at Bloomberg
07:03AM  What's driving the Nasdaq? These 5 stocks CNBC
Feb-23-15 07:58PM  Gilead Sciences, Inc., Amgen, Inc., Biogen Idec Inc Among Billionaires 5 Hottest Biotech Picks at Insider Monkey
04:12PM  How Gilead Sales Have Grown Conspicuously? at Investopedia
11:56AM  Gilead Sciences: Uh Oh, AbbVie Might Be Doing Better Than We Thought at Barrons.com
11:17AM  Biotech on the rise; Analyst likes Gilead CNBC
11:06AM  Big pharma invests big money in research and development Market Realist
08:41AM  Mylan to Distribute Gilead's Hepatitis C Drugs in India at The Wall Street Journal
08:14AM  How Obamacare Pits Insurers Against The Medical Industry at Forbes
Feb-20-15 08:41PM  Overheard: Gilead Needs More Tracks at The Wall Street Journal
03:08PM  Gilead Sciences: How Strong are Hepatitis-C Sales? at Barrons.com
03:07PM  Gilead's One Track Bind at The Wall Street Journal
12:28PM  What it takes to be called big pharma Market Realist
12:00PM  Will Express Scripts (ESRX) Beat Q4 Earnings Estimates? - Analyst Blog Zacks
08:30AM  FDA Fast-Track Should Accrete Significant Value to This Overlooked Biotech Company Spotlight
Feb-19-15 02:54PM  10 Most Popular Healthcare Stocks Among Hedge Funds at Insider Monkey
Feb-18-15 02:08PM  Nasdaq names leading the way CNBC
12:01AM  Gilead's Pill Can Stop HIV. So Why Does Almost Nobody Take It? Bloomberg
Feb-17-15 05:55PM  CVS urges cost controls for new cholesterol drugs Reuters
02:15PM  AbbVie: Amgen Circa 2011? at Barrons.com
11:45AM  Why Gilead Sciences Doesn't Seem Too Worried About AbbVie's Hep-C Treatment at Barrons.com
09:41AM  Apple Inc. (AAPL), Microsoft Corporation (MSFT), and Intel Corporation (INTC): Bridgewater Associates Reveals Top Picks at Insider Monkey
Feb-13-15 04:41PM  Netflix, Amazon Lead Q4 With Biggest Earnings Beat at Investor's Business Daily
10:31AM  Gilead Sciences: Hepatitis-C Tracking at High End of Guidance, RBC Says at Barrons.com
Feb-12-15 01:30PM  AbbVie Seeks Japanese Approval for HCV Cocktail Treatment - Analyst Blog Zacks
10:12AM  The Hepatitis C Scorecard: Gilead is Trouncing AbbVie, but at a Price at The Wall Street Journal
10:07AM  Are Sky-High Prices For New Drugs Justified? at Forbes
09:30AM  The Zacks Analyst Blog Highlights: Achillion Pharmaceuticals, Gilead, AbbVie, Regeneron and Alkermes - Press Releases Zacks
08:54AM  Gilead agrees 41,000 eur hep-C drug price for 12 week treatment Reuters
08:44AM  Brookdale scales up in response to industry dynamics Market Realist
Feb-11-15 04:38PM  Gilead Sciences Shares Rise Amid Insider Buy, Conference Presentation Broadcast - Stocks in the News Zacks
11:47AM  Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analyst Blog Zacks
10:19AM  Gilead Sciences: 'Significant Reassurance to Skittish Investors' at Barrons.com
10:03AM  Hey Abbvie, Don't Start What You Can't Finish Yahoo Finance Contributors
07:54AM  JMP Securities Covers Mostly Good News From Pharma Pending More Visibility Benzinga
Feb-10-15 04:38PM  Gilead expects big increase in Europeans treated with hep C drug Reuters
11:10AM  Gilead Faces Sovaldi Patent Challenge in Europe by a Non-Profit Group at The Wall Street Journal
05:00AM  Gilead faces challenge to European patent on pricey hep C drug Reuters
Feb-09-15 05:00PM  Gilead Sciences to Present at Two Upcoming Investor Conferences Business Wire
03:38PM  Achillion Soars on 6 Week HCV Cure When Used with Gilead's Sofosbuvir - Stocks in the News Zacks
03:21PM  [video]Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More at TheStreet
12:24PM  Gilead Walloped by Lower Pricing View on Hepatitis C at Barrons.com
Feb-06-15 09:38PM  Gilead's Dividend Debut; GM Relents at Barrons.com
07:04PM  Tech Earnings Soar 17.3%, Largely Thanks To Apple Investor's Business Daily
05:47PM  Can Gilead Boost HCV Sales with Health Service Deals? - Analyst Blog Zacks
05:21PM  Drug price wars 'drive value': Medical exec at CNBC
03:37PM  Gilead Sciences (GILD) Stock Lower Today After Credit Suisse Downgrade at TheStreet
03:23PM  Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade at Barrons.com
03:19PM  Drug price battles CNBC
12:15PM  Credit Suisse Gives Up on Gilead, Sort Of at 24/7 Wall St.
09:34AM  Credit Suisse Downgrades Gilead Sciences, Sees Declining HCV Revenues Benzinga
09:11AM  Morning Movers: Frontier Communications Gains on Verizon Landline Purchase; Gilead Drops on Downgrade at Barrons.com
06:05AM  Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx at TheStreet
Feb-05-15 03:18PM  No, the Gilead-AbbVie Price War Won't Derail the Pharmaceutical Rally at Barrons.com
09:30AM  The Zacks Analyst Blog Highlights: Amgen, Biogen, Celgene, AbbVie and Gilead - Press Releases Zacks
07:00AM  Gilead Sciences Inc. (GILD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-04-15 07:28PM  Gilead's Harvoni Investor's Business Daily -8.16%
07:28PM  Gilead Investor's Business Daily
06:41PM  Gilead's deep discounts fuel investor worries about drug pricing Reuters
05:46PM  Best biotech plays CNBC
04:44PM  S&P 500 Growth Gets a Boost From A Few Notable Earnings Reports Yahoo Finance Contributors
04:36PM  Midweek Market Recap.. Yahoo Finance Contributors
03:47PM  Gilead Sciences: Look on the Bright Side? at Barrons.com
03:05PM  Competition, discount worries weigh on Gilead shares AP
01:55PM  Gilead to discount its pricey Sovaldi drug at MarketWatch
01:27PM  Gilead sinks on discounting worries at Financial Times
12:49PM  Gilead Down on Discounting News at The Wall Street Journal
12:37PM  Gilead Dislodges a Brick in the Biotech Wall of Worry Yahoo Finance Contributors
12:36PM  Safe biotech plays CNBC
12:15PM  What the 'Shocking' Gilead Discounts on its Hepatitis C Drugs Will Mean at The Wall Street Journal
12:13PM  Pricing wars heat up over hepatitis C drugs at CNBC
12:12PM  HCV Stocks Struggle As Gilead, Merck Face Headwinds at Investor's Business Daily
11:59AM  Gilead Sciences Getting Crushed On Mixed Results Benzinga
11:47AM  Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog Zacks
11:26AM  Drugmaker Merck posts spike in 4Q profit, beats forecasts AP
11:04AM  Hepatitis Quest Moves From C to B Under Ex-Gilead Leaders at Bloomberg
10:58AM  Jim Cramer: Don't Bail on Biotech or Chipotle Mexican Grill at TheStreet
10:45AM  Gilead Dividend and Buyback Different From Amgens Strategy at 24/7 Wall St.
10:43AM  Stocks, Volume Get Mixed Start; Sony, Manhattan, Noah Spike at Investor's Business Daily
10:22AM  Will Dividend Investors Find Gilead? at Barrons.com
10:20AM  Humana's Medicare Business Booms But So Do Flu Costs at Forbes
10:14AM  Gilead Sciences: Hep-C Price War Takes Its Toll at Barrons.com
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. The company's products include Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Sovaldi, Viread, and Hepsera products for the treatment of liver disease. It also offers Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; Vistide, an antiviral injection for the treatment of cytomegalovirus retinitis in adult patients with AIDS; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages for the treatment of HIV, liver, oncology/inflammation, cardiovascular, and respiratory diseases. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaborations with BMS, Janssen, and Japan Tobacco to develop and commercialize various products. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 17Option Exercise16.4070,0001,147,650235,168Feb 19 06:42 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 17Sale103.0170,0007,210,740165,168Feb 19 06:42 PM
WOLD OLSEN PERDirectorFeb 06Buy99.9210,000999,15088,173Feb 10 04:30 PM
MARTIN JOHN CChairman and CEOFeb 02Option Exercise14.50150,0002,175,3754,272,987Feb 04 08:15 PM
Washington Robin LEVP, CFOFeb 02Option Exercise25.1433,192834,58683,024Feb 04 08:52 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 02Option Exercise19.0910,000190,850123,694Feb 04 08:51 PM
Carter Paul RutherfordEVP Commercial OpsFeb 02Option Exercise80.652,000161,30036,308Feb 04 08:52 PM
Whitley Richard JamesDirectorFeb 02Option Exercise26.995,000134,95020,641Feb 04 04:04 PM
MARTIN JOHN CChairman and CEOFeb 02Sale105.43150,00015,815,2494,122,987Feb 04 08:15 PM
Washington Robin LEVP, CFOFeb 02Sale105.3833,1923,497,66249,832Feb 04 08:52 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 02Sale105.7312,0001,268,719111,694Feb 04 08:51 PM
Carter Paul RutherfordEVP Commercial OpsFeb 02Sale106.152,000212,31034,308Feb 04 08:52 PM
Whitley Richard JamesDirectorFeb 02Sale105.675,000528,35815,641Feb 04 04:04 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 15Option Exercise16.4070,0001,147,650189,302Jan 20 12:46 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 15Sale98.4770,0006,893,083119,302Jan 20 12:46 PM
Carter Paul RutherfordEVP Commercial OpsJan 08Option Exercise36.721,00036,72035,308Jan 12 03:55 PM
Carter Paul RutherfordEVP Commercial OpsJan 08Sale100.881,000100,88134,308Jan 12 03:55 PM
MARTIN JOHN CChairman and CEOJan 05Sale96.651009,6654,122,987Jan 06 04:20 PM
Carter Paul RutherfordEVP Commercial OpsJan 02Option Exercise40.561,00040,56035,308Jan 06 04:21 PM
Whitley Richard JamesDirectorJan 02Option Exercise26.995,000134,95020,641Jan 06 02:12 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Option Exercise19.095,00095,425120,694Jan 06 04:20 PM
MARTIN JOHN CChairman and CEOJan 02Option Exercise14.50150,0002,175,3754,272,987Jan 06 04:20 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Sale95.177,000666,192113,694Jan 06 04:20 PM
Whitley Richard JamesDirectorJan 02Sale95.225,000476,10015,641Jan 06 02:12 PM
Carter Paul RutherfordEVP Commercial OpsJan 02Sale95.051,00095,05034,308Jan 06 04:21 PM
MARTIN JOHN CChairman and CEOJan 02Sale95.11149,90014,257,7224,123,087Jan 06 04:20 PM
Cogan John FrancisDirectorDec 22Option Exercise14.3426,000372,77568,405Dec 24 12:58 PM
Cogan John FrancisDirectorDec 22Sale95.0326,0002,470,75542,405Dec 24 12:58 PM
MILLIGAN JOHN FPresident and COODec 08Option Exercise8.01146,8231,175,3181,120,871Dec 10 05:32 PM
MILLIGAN JOHN FPresident and COODec 08Sale106.26146,82315,601,122974,048Dec 10 05:32 PM
MARTIN JOHN CChairman and CEODec 01Option Exercise8.01140,6331,125,7674,263,620Dec 03 07:13 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Option Exercise40.562,00081,12036,308Dec 03 07:14 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Option Exercise24.2931,000752,947149,694Dec 03 07:13 PM
Whitley Richard JamesDirectorDec 01Option Exercise26.995,000134,95020,641Dec 03 03:46 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Sale100.022,000200,03134,308Dec 03 07:14 PM
MARTIN JOHN CChairman and CEODec 01Sale100.72140,63314,164,8294,122,987Dec 03 07:13 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Sale100.7933,0003,325,922116,694Dec 03 07:13 PM
Whitley Richard JamesDirectorDec 01Sale100.195,000500,96915,641Dec 03 03:46 PM
Cogan John FrancisDirectorNov 21Option Exercise14.3425,000358,43867,405Nov 25 04:10 PM
Cogan John FrancisDirectorNov 21Sale101.2325,0002,530,77042,405Nov 25 04:10 PM
MILLIGAN JOHN FPresident and COONov 07Option Exercise8.01146,8951,175,8941,120,943Nov 12 12:48 PM
MILLIGAN JOHN FPresident and COONov 07Sale107.37146,89515,772,736974,048Nov 12 12:48 PM
Washington Robin LEVP, CFONov 05Option Exercise0.006,000055,832Nov 07 01:20 PM
Carter Paul RutherfordEVP Commercial OpsNov 04Option Exercise0.004,800037,044Nov 05 05:37 PM
Whitley Richard JamesDirectorNov 03Option Exercise26.995,000134,95020,641Nov 05 12:23 PM
MARTIN JOHN CChairman and CEONov 03Option Exercise8.01140,6251,125,7034,570,012Nov 05 02:05 PM
Carter Paul RutherfordEVP Commercial OpsNov 03Option Exercise40.563,000121,68035,244Nov 05 05:37 PM
Washington Robin LEVP, CFONov 03Option Exercise25.1433,192834,58683,024Nov 05 08:06 PM
MARTIN JOHN CChairman and CEONov 03Sale110.40140,62515,525,1024,429,387Nov 05 02:05 PM
Whitley Richard JamesDirectorNov 03Sale112.025,000560,09015,641Nov 05 12:23 PM
Carter Paul RutherfordEVP Commercial OpsNov 03Sale112.463,000337,38032,244Nov 05 05:37 PM
Washington Robin LEVP, CFONov 03Sale110.2633,1923,659,83749,832Nov 05 08:06 PM
Carter Paul RutherfordEVP Commercial OpsOct 24Option Exercise40.562,00081,12034,244Oct 28 01:35 PM
Carter Paul RutherfordEVP Commercial OpsOct 24Sale110.002,000220,00732,244Oct 28 01:35 PM
Cogan John FrancisDirectorOct 21Option Exercise14.3415,000215,06357,405Oct 23 01:54 PM
Cogan John FrancisDirectorOct 21Sale104.0815,0001,561,14942,405Oct 23 01:54 PM
MILLIGAN JOHN FPresident and COOOct 07Option Exercise8.01146,8951,175,8941,120,943Oct 09 02:10 PM
MILLIGAN JOHN FPresident and COOOct 07Sale104.60146,89515,365,818974,048Oct 09 02:10 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Option Exercise23.7631,000736,405153,694Oct 03 02:53 PM
MARTIN JOHN CChairman and CEOOct 01Option Exercise8.01140,6251,125,7034,570,012Oct 03 02:57 PM
MARTIN JOHN CChairman and CEOOct 01Sale105.91140,62514,893,8454,429,387Oct 03 02:57 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Sale105.9833,0003,497,259120,694Oct 03 02:53 PM
Carter Paul RutherfordEVP Commercial OpsSep 26Option Exercise40.562,00081,12034,244Sep 30 01:19 PM
Carter Paul RutherfordEVP Commercial OpsSep 26Sale107.472,000214,94532,244Sep 30 01:19 PM
Cogan John FrancisDirectorSep 22Option Exercise14.345,00071,68847,405Sep 24 01:20 PM
Cogan John FrancisDirectorSep 22Sale106.605,000532,98742,405Sep 24 01:20 PM
MILLIGAN JOHN FPresident and COOSep 08Option Exercise8.01146,8951,175,8941,120,943Sep 10 04:06 PM
MILLIGAN JOHN FPresident and COOSep 08Sale105.99146,89515,569,664974,048Sep 10 04:06 PM
Alton Gregg HEVP, Corp & Med AffairsSep 02Option Exercise23.7631,000736,405155,694Sep 04 05:09 PM
MARTIN JOHN CChairman and CEOSep 02Option Exercise8.01140,6251,125,7034,570,012Sep 04 05:09 PM
Whitley Richard JamesDirectorSep 02Option Exercise26.995,000134,95020,641Sep 04 04:31 PM
Whitley Richard JamesDirectorSep 02Sale108.105,000540,50015,641Sep 04 04:31 PM
Alton Gregg HEVP, Corp & Med AffairsSep 02Sale108.5833,0003,583,230122,694Sep 04 05:09 PM
MARTIN JOHN CChairman and CEOSep 02Sale108.64140,62515,277,9144,429,387Sep 04 05:09 PM
Carter Paul RutherfordEVP Commercial OpsAug 26Option Exercise19.0910,000190,85042,244Aug 28 02:35 PM
Carter Paul RutherfordEVP Commercial OpsAug 26Sale106.1610,0001,061,61832,244Aug 28 02:35 PM
Cogan John FrancisDirectorAug 21Option Exercise14.345,00071,68847,405Aug 25 12:21 PM
Cogan John FrancisDirectorAug 21Sale101.095,000505,44042,405Aug 25 12:21 PM
Washington Robin LEVP, CFOAug 14Option Exercise40.5633,5561,361,03183,388Aug 18 01:10 PM
Washington Robin LEVP, CFOAug 14Sale95.5633,5563,206,61149,832Aug 18 01:10 PM
Carter Paul RutherfordEVP Commercial OpsAug 08Option Exercise26.9916,728451,48948,713Aug 12 04:25 PM
Carter Paul RutherfordEVP Commercial OpsAug 08Sale91.5816,7281,531,88131,985Aug 12 04:25 PM
Washington Robin LEVP, CFOAug 01Option Exercise22.3030,600682,49080,432Aug 05 01:35 PM
Whitley Richard JamesDirectorAug 01Option Exercise26.995,000134,95020,641Aug 05 05:31 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Option Exercise0.002,500033,205Aug 05 05:31 PM
MARTIN JOHN CChairman and CEOAug 01Option Exercise8.01140,6251,125,7034,570,012Aug 04 06:16 PM
MARTIN JOHN CChairman and CEOAug 01Sale91.53140,62512,871,8134,429,387Aug 04 06:16 PM
Whitley Richard JamesDirectorAug 01Sale91.005,000455,00015,641Aug 05 05:31 PM
Washington Robin LEVP, CFOAug 01Sale91.4830,6002,799,34849,832Aug 05 01:35 PM
MOORE NICHOLAS GDirectorJul 28Option Exercise26.6245,0001,197,67545,000Jul 30 12:17 PM
MOORE NICHOLAS GDirectorJul 28Sale90.5645,0004,075,4030Jul 30 12:17 PM
Cogan John FrancisDirectorJul 21Option Exercise14.345,00071,68847,405Jul 23 01:31 PM
Cogan John FrancisDirectorJul 21Sale89.675,000448,34342,405Jul 23 01:31 PM
Carter Paul RutherfordEVP Commercial OpsJul 08Option Exercise26.9916,728451,48947,433Jul 10 01:41 PM
Carter Paul RutherfordEVP Commercial OpsJul 08Sale86.4516,7281,446,07430,705Jul 10 01:41 PM
Whitley Richard JamesDirectorJul 01Option Exercise26.995,000134,95020,641Jul 02 04:24 PM
MARTIN JOHN CChairman and CEOJul 01Option Exercise8.01140,6251,125,7034,570,012Jul 03 02:28 PM
Alton Gregg HEVP, Corp & Med AffairsJul 01Option Exercise23.6131,000731,853159,694Jul 03 03:14 PM
Alton Gregg HEVP, Corp & Med AffairsJul 01Sale84.1233,0002,776,076126,694Jul 03 03:14 PM
MARTIN JOHN CChairman and CEOJul 01Sale84.84140,62511,929,9614,429,387Jul 03 02:28 PM
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E30.21 EPS (ttm)8.98 Insider Own0.10% Shs Outstand613.90M Perf Week-0.62%
Market Cap166.56B Forward P/E22.62 EPS next Y11.99 Insider Trans-7.72% Shs Float486.17M Perf Month10.33%
Income5.58B PEG1.81 EPS next Q2.50 Inst Own93.90% Short Float3.00% Perf Quarter5.65%
Sales12.93B P/S12.88 EPS this Y13.60% Inst Trans0.93% Short Ratio5.74 Perf Half Y25.42%
Book/sh45.14 P/B6.01 EPS next Y15.70% ROA18.30% Target Price290.24 Perf Year20.81%
Cash/sh9.16 P/C29.63 EPS next 5Y16.70% ROE25.40% 52W Range193.37 - 274.50 Perf YTD3.66%
Dividend1.92 P/FCF28.52 EPS past 5Y25.30% ROI19.70% 52W High-1.16% Beta0.81
Dividend %0.71% Quick Ratio1.70 Sales past 5Y12.90% Gross Margin- 52W Low40.30% ATR4.36
Employees9500 Current Ratio1.70 Sales Q/Q7.20% Oper. Margin64.30% RSI (14)57.42 Volatility1.04% 1.61%
OptionableYes Debt/Eq0.00 EPS Q/Q15.00% Profit Margin54.00% Rel Volume0.78 Prev Close273.75
ShortableYes LT Debt/Eq0.00 EarningsJan 29 AMC Payout15.00% Avg Volume2.54M Price271.31
Recom1.90 SMA201.83% SMA503.54% SMA20017.56% Volume1,982,831 Change-0.89%
Jan-30-15Reiterated Stifel Buy $280 → $308
Jan-30-15Reiterated Argus Buy $295 → $300
Jan-30-15Downgrade FBR Capital Outperform → Mkt Perform $260
Jan-23-15Reiterated Oppenheimer Outperform $250 → $290
Dec-08-14Reiterated Argus Buy $260 → $295
Nov-12-14Initiated Topeka Capital Markets Hold $261
Oct-31-14Upgrade Argus Hold → Buy $260
Oct-30-14Upgrade FBR Capital Mkt Perform → Outperform $250 → $260
Oct-30-14Reiterated Stifel Buy $281 → $280
Oct-24-14Reiterated Oppenheimer Outperform $270 → $250
Apr-25-14Reiterated RBC Capital Mkts Outperform $263 → $250
Apr-14-14Upgrade Robert W. Baird Neutral → Outperform $245
Apr-14-14Initiated Pacific Crest Outperform $241
Jan-31-14Reiterated FBR Capital Mkt Perform $210 → $250
Jan-21-14Reiterated Stifel Buy $255 → $292
Jan-16-14Reiterated Barclays Overweight $240 → $270
Oct-31-13Reiterated FBR Capital Mkt Perform $190 → $210
Oct-28-13Reiterated Barclays Overweight $215 → $240
Aug-02-13Reiterated Stifel Buy $217
Jul-25-13Reiterated UBS Neutral $199 → $202
Feb-27-15 06:22PM  VISA INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements a EDGAR Online
01:53PM  Visa To Buy TrialPay For Undisclosed Amount Benzinga
12:00PM  Visa to Acquire TrialPay Business Wire
09:05AM  Tiger Global Management reduces position in Visa Market Realist
09:00AM  Visa Inc. to Participate in Upcoming Investor Conferences Business Wire
Feb-26-15 11:26AM  Visa Partners with Financial Institutions Across the Globe to Enable Mobile Payment Services Business Wire
12:10AM  Credit card switch to chips moves slowly at USA TODAY
Feb-25-15 09:30AM  The Zacks Analyst Blog Highlights: MasterCard, Visa, Total System Services and American Express - Press Releases Zacks
Feb-24-15 06:36PM  Popular Places Where U.S. Citizens Need A Visa at Investopedia
06:00PM  If you watch one thing today make it this CNBC
02:13PM  Immigrant spouses find relief with new H-4 visa rule CNNMoney.com
11:07AM  Visa Europe Paves the Way to Bring Apple Pay Across the Pond Entrepreneur
10:03AM  What's Driving Card Processors to All-Time Highs? - Analyst Blog Zacks
09:03AM  Tech Five: HP reports earnings after bell at USA TODAY
05:43AM  Visa Europe plans new security that could pave way for Apple Pay Reuters
03:16AM  Visa Europe plans credit card-cloaking that could pave way for Apple Pay Reuters
Feb-23-15 01:00PM  First Nation Bands to Benefit From Innovative Payment Solution Marketwired
Feb-20-15 05:06PM  Visa Expands Checkout Service, Aims 16 New Markets by 2015 - Analyst Blog Zacks
05:00PM  Will AmEx Continue to Skid Post-DoJ Trial, Costco & JetBlue? - Analyst Blog Zacks
01:10PM  Mastercard Inc (MA), Visa Inc (V), Citigroup Inc (C): Billionaires Are Crazy About These Financial Stocks at Insider Monkey
12:36AM  [$$] Visa Reaches Deal with Russia Over Payment System at The Wall Street Journal
Feb-19-15 04:49PM  American Express Antitrust Ruling Won't Help Consumers at Forbes
12:56PM  DOJ, States Beat American Express In Merchant Fee Case at Investor's Business Daily
12:49PM  American Express card rules violated U.S. antitrust law - judge Reuters
12:04PM  Visa Reaches Deal with Russia at The Wall Street Journal
09:26AM  Visa agrees to process Russian card transactions on local system Reuters
08:10AM  Billionaires Are Crazy About These 10 Stocks at Insider Monkey
08:00AM  Visa Extends Easy and Secure Online Payments to New Markets Through Roll-out of Visa Checkout Business Wire
06:00AM  Canadians Prioritize Security Over Convenience, Speed When Making Payments Marketwired
Feb-18-15 06:52PM  Sale of Energy Stocks the Biggest Highlight in Berkshire's 4Q Equity Portfolio Morningstar
Feb-17-15 02:07PM  [$$] Apple Pay Overshadows Mobile World Congress at Barrons.com
11:47AM  Correction: Visa-Travel Tracker story AP
05:37AM  Monitise, up for sale, says in "constructive" talks Reuters
Feb-16-15 10:30AM  Heartland Payment Misses on Q4 Estimates; Hikes Dividend - Analyst Blog Zacks
Feb-13-15 11:59PM  Visa's secure payment system is expanding to online shopping at Engadget
11:57PM  Visa, MasterCard to Roll Out New Cybersecurity Features at The Wall Street Journal
11:05PM  Fisher Asset Management decreases position in Visa Market Realist
05:05PM  To combat fraud, Visa wants to track your smartphone AP
04:17PM  To combat fraud, Visa wants to track your smartphone at Los Angeles Times
02:46PM  Visa, MasterCard Roll Out Security Features at The Wall Street Journal
01:49PM  Visa, MasterCard Unveil Cybersecurity Features, and More at MarketWatch
12:07PM  Visa, MasterCard will shell out millions to beef up cyber defenses at Fortune
12:01PM  Visa, MasterCard Debut New Cybersecurity Tech at Investor's Business Daily
06:00AM  Visa to Remove 16-Digit Account Number in Online and Mobile Payments Business Wire
05:08AM  Visa wants to track your travels abroad to prevent declined payments at Engadget
Feb-12-15 11:41PM  Many Americans socking away their gas windfall at USA TODAY
02:35PM  Top Performing Tech Funds Perk Up at Investor's Business Daily
02:03PM  Visa wants to track your smartphone to prevent credit card fraud Gigaom
12:52PM  What the Costco-AmEx Split Means for Shoppers at The Wall Street Journal
09:09AM  Obama's cybersecurity summit: More flash than substance Yahoo Finance
08:00AM  Visa Launches Mobile Location Service to Improve Card Payment Experience When Traveling Business Wire
Feb-11-15 12:59PM  Apple Inc. (AAPL), Visa Inc (V), Actavis plc (ACT): Laurion Capital Reveals Top Stock Picks at Insider Monkey
06:20AM  Cramer: Here's One Airline to Own TheStreet
Feb-10-15 10:00AM  WEX Inc Misses Q4 Earnings Expectations, Declines Y/Y - Analyst Blog Zacks
08:00AM  Visa Showcases Connected Commerce at Mobile World Congress 2015 Business Wire
Feb-09-15 03:30PM  Richest Americans prefer cash back CNBC
09:34AM  Highlights of Fisher Asset Managements 4Q14 positions Market Realist
Feb-07-15 12:01AM  A 15% Upside for Vantiv at Barrons.com
Feb-06-15 04:00PM  Stocks close down, but post strong weekly gains at CNBC
09:42AM  FleetCor Technologies Beats on Q4 Earnings and Revenues - Analyst Blog Zacks
12:00AM  Visa Pre-Sale Opens for FIFA Womens World Cup Canada 2015 Business Wire
12:00AM  Visa Pre-Sale Opens for FIFA Women's World Cup Canada 2015(TM) Marketwired
Feb-05-15 05:33PM  Too Much Diversification Spoils Rather Than Helps Portfolio Gain Investor's Business Daily
01:04PM  VISA INC. Financials EDGAR Online Financials
11:31AM  Alliance Data Systems Tops Views, But Stock Sinks at Investor's Business Daily
Feb-04-15 04:59PM  Stocks Finished Mixed After ECB Statements On Greece at Investor's Business Daily
04:26PM  Stocks End Mixed As Oil Sinks; Apple Clears Buy Point at Investor's Business Daily
02:50PM  Stocks Fade In Late Trade; Hain Celestial Jumps at Investor's Business Daily
Feb-03-15 08:48PM  Visa Lays Out Cash for New CFO at The Wall Street Journal
03:08PM  CFO Moves: Visa, Array BioPharma, Epizyme at The Wall Street Journal
02:56PM  Apple Pay institution count rises to 60 at CNBC
12:36PM  NXP Aims To Gain On Mobile Wallet With Q4 Earnings at Investor's Business Daily
10:12AM  Time to take a step back. Yahoo Finance Contributors
Feb-02-15 05:05PM  Visa Names NBCUniversals Prabhu as CFO, Succeeding Pollitt at Bloomberg
04:56PM  Visa hires NBCUniversal's Prabhu as its new CFO AP
04:44PM  Visa Names NBCUniversal Executive As Finance Chief at The Wall Street Journal
04:23PM  Visa names Vasant Prabhu CFO at MarketWatch
04:21PM  VISA INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04:15PM  Visa Inc. Appoints Vasant M. Prabhu as Chief Financial Officer Business Wire
03:45PM  Visa vs. MasterCard: Is There a Difference? at Investopedia
08:30AM  Visa Inc. to Participate in Upcoming Investor Conferences Business Wire
07:00AM  Visa Inc. (V): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-31-15 07:07PM  10-Q for Visa, Inc. Company Spotlight
Jan-30-15 08:14PM  What did Visas earnings reveal about consumer spending? Fox Business Video
06:00PM  Cramer preps for the week ahead: Exxon, Disney & jobs CNBC
01:47PM  Indexes Mired In Red; Amazon, Biogen, Visa Buck Trend at Investor's Business Daily
01:38PM  Visa & MasterCard Lead The 'Digital Dollars Index' Benzinga
01:17PM  US stock markets lower on mixed US economic data AP
01:04PM  The read on Apple, Visa & Chevron CNBC
12:59PM  Goldman Sachs to replace Visa as Dows top dog at MarketWatch
12:41PM  MasterCard Beats on Q4 Earnings, Expenses Mar Margins - Analyst Blog Zacks
12:27PM  Visa (V) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
12:10PM  Visa (V) Posts Solid Q1 Earnings, Initiates 4:1 Stock Split - Analyst Blog Zacks
11:53AM  Story Stocks from Briefing.com Briefing.com
11:37AM  Here's How Visa's Stock Split Will Affect the Dow at The Wall Street Journal
11:29AM  Privacy is dead: How Twitter and Facebook are exposing you Yahoo Finance
10:54AM  MasterCard Beats In Q4, Expects Challenges In '15 at Investor's Business Daily
09:39AM  Market awaits SHAK IPO CNBC
09:35AM  Visa (V) Stock May Trade Lower Today Following Ratings Cut at TheStreet
09:33AM  Citigroup: There's More To Visa Than A Stock Split Benzinga
Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. It owns and operates VisaNet that is involved in the authorization, clearing, and settlement of payment transactions; and provision of fraud protection for account holders and assured payment for merchants. The company also offers a range of issuer processing services for participating issuers of Visa debit, prepaid, and ATM payment products. In addition, it provides electronic payment, risk management, and payment security solutions to online merchants; digital goods transactions services in online games, digital media, and social networks; and mobile financial services for mobile network operators and financial institutions in developing economies. The company offers its services under the Visa, Visa Electron, Interlink, and PLUS brands. Visa Inc. is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHEY ELLENVICE CHAIR RISK & PUB POLICYFeb 09Sale267.417,9662,130,18814,622Feb 11 06:13 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERFeb 02Sale255.893,438879,75044,446Feb 04 06:57 PM
Sheedy William M.EVP CORP STRAT, M&A, GRNov 11Option Exercise0.0025,4320115,997Nov 13 06:49 PM
Sheedy William M.EVP CORP STRAT, M&A, GRNov 11Sale249.1725,4326,336,89190,565Nov 13 06:49 PM
RICHEY ELLENVICE CHAIR RISK & PUB POLICYNov 05Option Exercise0.001,125012,820Nov 07 05:45 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERSep 03Option Exercise0.004,867063,897Sep 04 04:35 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERSep 03Sale215.0714,5453,128,19349,352Sep 04 04:35 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJun 16Option Exercise0.003,582066,334Jun 17 06:39 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJun 16Sale210.887,3041,540,26859,030Jun 17 06:39 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERMay 08Option Exercise0.0079,518097,351May 12 05:55 PM
POLLITT BYRON H JRCHIEF FINANCIAL OFFICERMay 08Sale210.0079,51816,698,78017,833May 12 05:55 PM
KELLY ALFRED F JRDirectorMar 17Buy222.701,575350,7531,575Mar 18 06:21 PM
PPG [NYSE]
PPG Industries Inc.
IndexS&P 500 P/E29.98 EPS (ttm)7.85 Insider Own0.30% Shs Outstand136.05M Perf Week-0.53%
Market Cap32.02B Forward P/E18.12 EPS next Y12.99 Insider Trans-36.25% Shs Float135.56M Perf Month6.45%
Income1.10B PEG2.32 EPS next Q2.37 Inst Own72.70% Short Float0.90% Perf Quarter9.59%
Sales15.36B P/S2.08 EPS this Y34.30% Inst Trans1.41% Short Ratio1.56 Perf Half Y15.39%
Book/sh44.58 P/B5.28 EPS next Y12.84% ROA12.50% Target Price254.88 Perf Year23.10%
Cash/sh22.33 P/C10.54 EPS next 5Y12.93% ROE36.10% 52W Range170.51 - 237.41 Perf YTD2.12%
Dividend2.68 P/FCF- EPS past 5Y31.10% ROI15.10% 52W High-0.86% Beta1.26
Dividend %1.14% Quick Ratio1.40 Sales past 5Y4.60% Gross Margin42.80% 52W Low38.04% ATR3.50
Employees41400 Current Ratio1.80 Sales Q/Q5.90% Oper. Margin9.90% RSI (14)57.78 Volatility0.96% 1.51%
OptionableYes Debt/Eq0.55 EPS Q/Q-59.20% Profit Margin13.70% Rel Volume0.89 Prev Close235.84
ShortableYes LT Debt/Eq0.48 EarningsJan 15 BMO Payout17.30% Avg Volume778.57K Price235.38
Recom1.90 SMA201.86% SMA503.08% SMA20013.03% Volume695,830 Change-0.20%
Jan-16-15Reiterated Argus Buy $238 → $271
Oct-17-14Reiterated RBC Capital Mkts Outperform $250 → $243
Oct-09-14Initiated RBC Capital Mkts Outperform $250
Jul-01-14Reiterated Deutsche Bank Buy $220 → $235
Apr-25-14Reiterated Argus Buy $216 → $224
Apr-21-14Reiterated Deutsche Bank Buy $213 → $220
Dec-06-13Reiterated Deutsche Bank Buy $195 → $210
Jul-22-13Reiterated UBS Neutral $148 → $156
Jul-22-13Reiterated RBC Capital Mkts Outperform $160 → $176
Jul-22-13Reiterated Barclays Equal Weight $157 → $167
Feb-12-13Resumed Barclays Equal Weight $149
Jan-23-13Reiterated Argus Buy $136 → $157
Jan-04-13Reiterated UBS Neutral $118 → $136
Dec-18-12Reiterated Deutsche Bank Buy $132 → $150
Aug-08-12Reiterated UBS Neutral $98 → $111
Jun-22-12Initiated Robert W. Baird Outperform $120
Apr-20-12Reiterated UBS Neutral $90 → $98
Apr-10-12Reiterated Barclays Equal Weight $101 → $105
Feb-01-12Reiterated Barclays Capital Equal Weight $92 → $101
Nov-18-11Reiterated Barclays Capital Equal Weight $85 → $93
Feb-26-15 01:04PM  PPG INDUSTRIES INC Financials EDGAR Online Financials
Feb-25-15 09:44AM  Valspar (VAL) Beats Q1 Earnings and Revenue Estimates - Analyst Blog Zacks
Feb-24-15 06:47PM  PPG Industries Unveils Duraform Coating for Garage Doors - Analyst Blog Zacks
10:12AM  5 Commodity Stocks Showing Breakout Gains in March at TheStreet
Feb-21-15 07:08PM  10-K for PPG Industries, Inc. Company Spotlight
Feb-20-15 04:42PM  Friday's Market Recap Yahoo Finance Contributors
Feb-19-15 01:33PM  LIQUID NAILS Brand by PPG Expands Extreme Line of Products With Extreme Landscape Block Business Wire
01:04PM  PPG INDUSTRIES INC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
12:32PM  PPG Appoints McGarry President and Chief Operating Officer Business Wire
12:02PM  Axiall Holdco, Inc. -- Moody's assigns a Ba1 rating to Axiall's new $250 million Senior Secured Term Loan at Moody's
11:43AM  PPG INDUSTRIES INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-18-15 03:49PM  PPG Showcasing Duranar Products at Frame Expo - Analyst Blog Zacks
Feb-16-15 01:30PM  PPG Industries (PPG) Strikes New 52-Week High at $236.85 - Analyst Blog Zacks
10:28AM  Should Investors Follow 'Smart Money' And Bet On an Oil Rebound? at TheStreet
Feb-04-15 07:34PM  PPG Industries to Expand Silica Capacity in Netherlands - Analyst Blog Zacks
Feb-03-15 08:07AM  PPG to Increase Silica Production Capacity at Delfzijl, Netherlands, Plant Business Wire
Feb-02-15 06:45PM  PPG Buying Stake in Le Joint Francais Sealants Businesses - Analyst Blog Zacks
Jan-30-15 10:30AM  PPG to acquire majority interest in French aerospace and automotive sealants business at American City Business Journals
09:07AM  PPG Submits Offer to Acquire Majority Interest in Aerospace and Automotive Sealants Businesses of Le Joint Francais Business Wire
Jan-29-15 12:31PM  Sherwin-Williams '15 EPS Outlook Below Analyst Views at Investor's Business Daily
11:25AM  Sherwin-Williams' Q4 Earnings Top Estimates, Profit Rises - Analyst Blog Zacks
09:03AM  PPG Announces All-New Brand to Better Serve Independent Dealers and Paint Professionals Business Wire
Jan-22-15 04:33PM  DuPonts Performance Chemicals spinoff is on track Market Realist
Jan-21-15 06:32PM  PPG Strongly Placed on Acquisitions, Key Market Strength - Analyst Blog Zacks
01:40PM  Materials ETFs Mauled by Falling Oil Prices ETF Trends
Jan-20-15 04:14PM  People Moves: General Cable, Activis, Boies Schiller at The Wall Street Journal
08:52AM  Cramer: It's not that kind of earnings season CNBC
Jan-19-15 07:00AM  PPG Industries Inc. (PPG): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-18-15 12:40PM  Deutsche Bank's 4 Industrial Stocks To Buy Benzinga
Jan-17-15 07:30PM  Pittsburgh manufacturers driving the future of automobiles behind the scenes (Video) at American City Business Journals
Jan-16-15 02:36PM  PPG INDUSTRIES INC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
11:03AM  Deutsche Bank Raises Price Target On PPG Industries Benzinga
09:33AM  PPG Senior Vice President Navikas to Retire Business Wire
Jan-15-15 05:02PM  PPG Industries (PPG) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
02:36PM  PPG Industries Comex Purchase Helps Paint Bright Q4 at Investor's Business Daily
02:00PM  PPG Industries Inc Earnings Call scheduled for 2:00 pm ET today CCBN
12:17PM  PPG Industries (PPG) Stock Gains Today Following Realease of Fourth Quarter Results at TheStreet
11:28AM  PPG Industries (PPG) Q4 Earnings Trump, Charges Dent Net - Analyst Blog Zacks
11:17AM  PPG INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
10:01AM  PPG Directors Announce Quarterly Dividend of 67 Cents Per Share Business Wire
09:44AM  PPG Industries' Sales Rise at The Wall Street Journal
09:38AM  PPG Industries (PPG) Q4 Earnings Top on Volume gains - Tale of the Tape Zacks
08:27AM  PPG Industries beats Street 4Q forecasts AP
08:11AM  PPG Reports Record Fourth Quarter and Full-Year Net Sales and Adjusted Earnings Business Wire
07:23AM  Investors aren't giving Visa enough credit: Expert CNBC
07:07AM  Q4 2014 PPG Industries Inc Earnings Release - Before Market Open CCBN
Jan-09-15 06:10PM  Cramer's game plan: A new ball game for earnings at CNBC
06:00PM  Cramer: Last chance to buy this stock CNBC
Jan-07-15 06:51PM  Lightning Round: Cramer's most loved stock at CNBC
06:00AM  Jim Cramer's Top Stock Picks: WFC PPG JCP OVAS MCD at TheStreet
Jan-06-15 08:25PM  [video]Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains at TheStreet
Jan-05-15 11:29AM  PPG to Announce Fourth Quarter 2014 Results Jan. 15, 2015 Business Wire
Dec-26-14 08:13AM  7 Best and Worst Chemical Stocks for the Era of Lower Oil Prices at TheStreet
Dec-22-14 12:45PM  5 Technology Stocks Trade for Gains This Week: NetApp and More at TheStreet
Dec-19-14 08:50AM  PPG Enters into Exclusive Negotiations to Acquire Automotive Specialty Materials Manufacturer REVOCOAT Business Wire
Dec-18-14 05:41PM  A Look at Thursday's Market Yahoo Finance Blogs
09:22AM  Will This Price Target Increase Help PPG Industries (PPG) Stock Today? at TheStreet
Dec-12-14 01:00PM  Sherwin-Williams Strikes New 52-Week High at $256.16 Zacks
Dec-10-14 03:20PM  PPG Industries to Provide Gulfstream Windows, Assemblies Zacks
Dec-09-14 11:37AM  GLIDDEN PROFESSIONAL Launches Marketing Toolkit for the Pros Business Wire
10:50AM  PPG Aerospace to Supply Gulfstream Windows, Assemblies for G500, G600 Jets Business Wire
Dec-05-14 06:57PM  Cramer: 3 things to make oil's bull case at CNBC
Dec-02-14 10:00PM  PPG Plant in Bangplee, Thailand, Recognized for Zero Workplace Accidents Business Wire
05:13PM  Morales of PPG to Present at Bank of America Merrill Lynch 2014 US Basic Materials Conference Business Wire
04:41PM  Today's Glance at the Market... Yahoo Finance Blogs
01:33PM  GLIDDEN Paint Invites NFL Fans to Share Their Team Colors Business Wire
Nov-26-14 08:15AM  Valspar Q4 Earnings & Revenues Top Estimates, Profits Rise Zacks
Nov-24-14 04:48PM  Most Sectors Represent in Today's Lg Cap All-Time Highs... Yahoo Finance Blogs
10:30AM  PPG Industries (PPG) Hits New 52-Week High at $217.73 Zacks
Nov-22-14 02:07PM  PPG Is Spot-On; The Hazards of Skepticism: Jim Cramer's Best Blogs TheStreet
Nov-20-14 04:31PM  PPG INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl EDGAR Online
Nov-19-14 05:35PM  PPG Industries (PPG) Launches New Olympic Home Paint Zacks
10:11AM  Bunch of PPG to present at 2014 Citi Basic Materials Conference Business Wire
Nov-18-14 08:10PM  Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous at TheStreet
07:32PM  Cramer Remix: Warning to the skeptics at CNBC
12:15PM  The OLYMPIC Brand Launches New HOME Interior Paint at Lowes Business Wire
07:03AM  PPG Data Shows White Continues to Dominate as Most Popular Global Vehicle Colour Business Wire
07:03AM  PPG Data Shows White Continues to Dominate as Most Popular Global Vehicle Color Business Wire
Nov-17-14 08:38AM  PPG Announces Completion Of Tender Offers To Purchase Certain Debt Securities, ~$90.3M Aggregate Benzinga
08:35AM  PPG Announces Completion of Tender Offers to Purchase Certain Debt Securities Business Wire
Nov-14-14 02:55PM  PPG Announces Pricing of Offers to Purchase Certain Debt Securities for Cash Business Wire
Nov-12-14 11:54AM  PPG INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl EDGAR Online
10:50AM  Sherwin-Williams (SHW) Hits New 52-Week High at $238.35 Zacks
Nov-07-14 05:20PM  PPG Industries (PPG) Wraps Up $2.3B Comex Buyout Zacks
08:20AM  PPG INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Nov-06-14 03:12PM  PPG Announces Pricing for Public Offering of Senior Notes Business Wire
03:03PM  PPG Appoints Marcos Achar Levy Vice President, Architectural Coatings, Mexico Business Wire
12:05PM  3 Chemicals Stocks Moving The Industry Upward at TheStreet
12:00PM  PPG Architectural Coatings Wins 2014 Monster of HR Award Business Wire
08:51AM  PPG INDUSTRIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:45AM  PPG Commences Public Offering of Senior Notes Business Wire
08:40AM  PPG Announces Tender Offers to Purchase Certain Debt Securities for Cash Business Wire
Nov-05-14 02:01PM  PPG INDUSTRIES INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and E EDGAR Online
12:35PM  PPG Industries finalizes $2.3 bln purchase of Mexico's Comex Reuters
11:05AM  PPG Completes Acquisition of Comex Business Wire
Nov-03-14 04:20PM  PPG Gets Favorable FECC Ruling for $2.3B Comex Buy Zacks
Nov-01-14 01:51PM  A Dramatically Overbought Market; Trust Facebook: Jim Cramer's Best Blogs at TheStreet
Oct-31-14 05:26PM  Today's Market Thorns, Roses, All Time Highs, and ETF All Time Highs Yahoo Finance Blogs +5.89%
03:24PM  PPG INDUSTRIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:44PM  PPG Receives Favorable Ruling from Federal Economic Competition Commission of Mexico on Comex Acquisition Business Wire
PPG Industries, Inc. manufactures and distributes coatings, optical and specialty materials, and glass products. The company operates in five segments: Performance Coatings, Industrial Coatings, Architectural Coatings, Optical and Specialty Materials, and Glass. It offers coatings products for automotive and commercial transport/fleet repair and refurbishing, light industrial coatings, and specialty coatings for signs; sealants, coatings, maintenance cleaners, and transparencies for commercial, military, regional jet, and general aviation aircraft and transparent armor for specialty applications; and coatings and finishes for the protection of metals and structures to metal fabricators, heavy duty maintenance contractors, and manufacturers of ships, bridges, and rail cars. The company also provides industrial and automotive coatings for manufacturing companies; adhesives and sealants for the automotive industry; metal pretreatments and related chemicals for industrial and automotive applications; and packaging coatings to aerosol, food, and beverage container manufacturers. In addition, it offers architectural coatings used by painting and maintenance contractors and by consumers to decorate and maintain residential and commercial building structures, as well as purchased sundries to painting contractors and consumers. Further, the company provides optical products, such as lenses, optical lens materials, and sun lenses; silicas comprising amorphous precipitated silicas for tire, battery separator, and other end-use markets; and substrates used for radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards applications. Additionally, it offers flat glass and continuous-strand fiber glass products for commercial and residential construction markets, and the wind energy, energy infrastructure, transportation, and electronics industries. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEKMAKAS VIKTORAS RExecutive Vice PresidentFeb 25Option Exercise89.9412,6641,139,00033,488Feb 27 04:03 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentFeb 25Sale236.3519,3784,579,99414,110Feb 27 04:03 PM
BUNCH CHARLES EChairman and CEOFeb 23Sale236.1720,0004,723,370380,536Feb 24 04:05 PM
BOST GLENN E IISr. VP & Gen. CounselFeb 20Option Exercise89.9414,5271,306,55836,365Feb 24 04:02 PM
BUNCH CHARLES EChairman and CEOFeb 20Sale233.9020,0004,678,091400,536Feb 24 04:05 PM
BOST GLENN E IISr. VP & Gen. CounselFeb 20Sale233.7819,8974,651,42116,468Feb 24 04:02 PM
BUNCH CHARLES EChairman and CEOFeb 18Option Exercise89.9470,7716,365,144444,949Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 18Sale234.4270,77116,590,277374,178Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 17Option Exercise89.9470,7716,365,144444,949Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 17Sale235.4970,77116,666,094374,178Feb 19 04:04 PM
RICHENHAGEN MARTINDirectorFeb 15Option Exercise0.001,27908,237Feb 17 09:03 AM
HOOPER MICHELE JDirectorFeb 15Option Exercise0.001,27905,625Feb 17 09:00 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevJan 23Option Exercise83.908,290695,53130,984Jan 27 03:47 PM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevJan 23Sale229.198,2901,899,98522,694Jan 27 03:47 PM
BOST GLENN E IISr. VP & Gen. CounselNov 14Option Exercise75.032,975223,21419,443Nov 17 10:30 AM
BOST GLENN E IISr. VP & Gen. CounselNov 14Sale205.112,975610,20216,468Nov 17 10:30 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevAug 14Option Exercise86.579,000779,10031,694Aug 15 09:01 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevAug 14Sale201.139,0001,810,19222,694Aug 15 09:01 AM
BUNCH CHARLES EChairman and CEOJul 22Option Exercise88.7047,7004,230,990421,878Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 22Sale210.1147,70010,022,272374,178Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 21Option Exercise88.7047,7004,230,990421,878Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 21Sale208.8147,7009,960,191374,178Jul 23 01:24 PM
NIEKAMP CYNTHIA ASr. VP, Automotive CoatingsApr 24Option Exercise88.708,700771,69037,981Apr 28 08:56 AM
NIEKAMP CYNTHIA ASr. VP, Automotive CoatingsApr 24Sale195.358,7001,699,58429,281Apr 28 08:56 AM
MCGARRY MICHAEL HExecutive Vice PresidentApr 23Option Exercise88.705,000443,50038,360Apr 24 09:14 AM
MCGARRY MICHAEL HExecutive Vice PresidentApr 23Sale197.385,000986,92133,360Apr 24 09:14 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentApr 22Option Exercise88.709,700860,39028,810Apr 23 09:14 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentApr 22Sale196.9114,7002,894,61714,110Apr 23 09:14 AM